<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2013.00117</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Amyloid-&#x003B2; induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nava-Mesa</surname> <given-names>Mauricio O.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jim&#x000E9;nez-D&#x000ED;az</surname> <given-names>Lydia</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yajeya</surname> <given-names>Javier</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Navarro-Lopez</surname> <given-names>Juan D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratorio Neurofisiolog&#x000ED;a y Comportamiento, Facultad de Medicina de Ciudad Real, Universidad de Castilla-La Mancha</institution> <country>Ciudad Real, Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Fisiolog&#x000ED;a y Farmacolog&#x000ED;a, Universidad de Salamanca</institution> <country>Salamanca, Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Enrico Cherubini, International School for Advanced Studies, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Lisa Topolnik, Laval University, Canada; Claudia Lodovichi, Venetian Institute of Molecular Medicine, Italy</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Juan D. Navarro-L&#x000F3;pez, Neurophysiology and Bahavior Lab, School of Medicine of Ciudad Real, University of Castilla-La Mancha, Paseo Moledores s/n, 13071-Ciudad Real, Spain e-mail: <email>juan.navarro&#x00040;uclm.es</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>07</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="collection">
<year>2013</year>
</pub-date>
<volume>7</volume>
<elocation-id>117</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>04</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>07</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013 Nava-Mesa, Jim&#x000E9;nez-D&#x000ED;az, Yajeya and Navarro-Lopez.</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.</p>
</license>
</permissions>
<abstract><p>Last evidences suggest that, in Alzheimer&#x00027;s disease (AD) early stage, Amyloid-&#x003B2; (A&#x003B2;) peptide induces an imbalance between excitatory and inhibitory neurotransmission systems resulting in the functional impairment of neural networks. Such alterations are particularly important in the septohippocampal system where learning and memory processes take place depending on accurate oscillatory activity tuned at fimbria-CA3 synapse. Here, the acute effects of A&#x003B2; on CA3 pyramidal neurons and their synaptic activation from septal part of the fimbria were studied in rats. A triphasic postsynaptic response defined by an excitatory potential (EPSP) followed by both early and late inhibitory potentials (IPSP) was evoked. The EPSP was glutamatergic acting on ionotropic receptors. The early IPSP was blocked by GABA<sub>A</sub> antagonists whereas the late IPSP was removed by GABA<sub>B</sub> antagonists. A&#x003B2; perfusion induced recorded cells to depolarize, increase their input resistance and decrease the late IPSP. A&#x003B2; action mechanism was localized at postsynaptic level and most likely linked to GABA<sub>B</sub>-related ion channels conductance decrease. In addition, it was found that the specific pharmacological modulation of the GABA<sub>B</sub> receptor effector, G-protein-coupled inward rectifier potassium (GirK) channels, mimicked all A&#x003B2; effects previously described. Thus, our findings suggest that A&#x003B2; altering GirK channels conductance in CA3 pyramidal neurons might have a key role in the septohippocampal activity dysfunction observed in AD.</p></abstract>
<kwd-group>
<kwd>septohippocampal system</kwd>
<kwd>fimbria-CA3 synapse</kwd>
<kwd>amyloid-&#x003B2;<sub>25&#x02013;35</sub> peptide</kwd>
<kwd>GABA<sub>B</sub></kwd>
<kwd>GirK channels</kwd>
<kwd>Alzheimer&#x00027;s disease</kwd>
<kwd>brain slices</kwd>
<kwd>intracellular recordings</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="80"/>
<page-count count="14"/>
<word-count count="10230"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>Being still lack of effective treatments for Alzheimer&#x00027;s disease (AD), current research efforts have focused on finding the relationships between amyloid-&#x003B2; peptide (A&#x003B2;) functions and toxic mechanisms to understand the development of AD (Huang and Mucke, <xref ref-type="bibr" rid="B27">2012</xref>). Memory deficits and disorientation appear as the first symptoms of AD (McKhann et al., <xref ref-type="bibr" rid="B45">1984</xref>; Swanberg et al., <xref ref-type="bibr" rid="B68">2004</xref>) and, among the different regions early affected, damages found in septum and hippocampus could explain these cognitive deficits (Moreno et al., <xref ref-type="bibr" rid="B49">2007</xref>; Palop et al., <xref ref-type="bibr" rid="B53">2007</xref>; Villette et al., <xref ref-type="bibr" rid="B72">2010</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>). Both structures are reciprocally interconnected through fimbria/fornix, and are functionally coupled to form the septohippocampal system (Bland and Colom, <xref ref-type="bibr" rid="B8">1993</xref>), which is critical in generating certain oscillatory activity, such as <italic>theta</italic> rhythm, necessary for fundamental processes in learning and memory (Stewart and Fox, <xref ref-type="bibr" rid="B66">1990</xref>; Bland and Oddie, <xref ref-type="bibr" rid="B9">2001</xref>; Buzsaki, <xref ref-type="bibr" rid="B12">2002</xref>; Sotty et al., <xref ref-type="bibr" rid="B63">2003</xref>; Colom, <xref ref-type="bibr" rid="B18">2006</xref>; Colom et al., <xref ref-type="bibr" rid="B19">2010</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>). <italic>Theta</italic> oscillation coordinates septohippocampal network and depends on interconnections, which include well known cholinergic and GABAergic (Lynch et al., <xref ref-type="bibr" rid="B41">1977</xref>; Kohler et al., <xref ref-type="bibr" rid="B32">1984</xref>; Bland and Colom, <xref ref-type="bibr" rid="B8">1993</xref>) as well as glutamatergic (Sotty et al., <xref ref-type="bibr" rid="B63">2003</xref>; Huh et al., <xref ref-type="bibr" rid="B28">2010</xref>) projections.</p>
<p>In animal models of AD, septohippocampal network dysfunction has extensively been reported (Colom, <xref ref-type="bibr" rid="B18">2006</xref>; Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>; Pe&#x000F1;a et al., <xref ref-type="bibr" rid="B55">2010</xref>; Villette et al., <xref ref-type="bibr" rid="B72">2010</xref>, <xref ref-type="bibr" rid="B71">2012</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>; Verret et al., <xref ref-type="bibr" rid="B70">2012</xref>). At the synaptic level, dysfunction induced by A&#x003B2; on inhibitory neurotransmission causes aberrant patterns of activity in its associated neural circuits, destabilizes neuronal networks and impairs oscillatory activity. This scenario, ultimately, seems to be responsible for the early alteration of the processes implicated in learning and memory tasks observed in AD patients (Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>; Huang and Mucke, <xref ref-type="bibr" rid="B27">2012</xref>). However, the specific mechanisms involving inhibitory neurotransmission at the molecular level, synaptic circuits or systems that consistently explain A&#x003B2; neurotoxic effects and associated neurological deficits remain unknown.</p>
<p>&#x003B3;-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the mammalian central nervous system and is involved in the regulation of many physiological processes. GABA mediates the inhibitory neurotransmission and accordingly, regulates excitatory activity preventing hyperexcitation, actions especially relevant to maintain neural network stability and oscillatory activity (Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>). GABA metabotropic type receptors (GABA<sub>B</sub>) are coupled to intracellular signal transduction mechanisms via G proteins (Mott and Lewis, <xref ref-type="bibr" rid="B50">1994</xref>; Kaupmann et al., <xref ref-type="bibr" rid="B30">1998</xref>) and mediate slow and prolonged synaptic inhibition mainly by postsynaptic G protein-coupled activated inwardly-rectifying potassium (GirK) channels (Luscher et al., <xref ref-type="bibr" rid="B39">1997</xref>; Kaupmann et al., <xref ref-type="bibr" rid="B30">1998</xref>). Thus, GirK channels act as key players in the control of cellular and network excitability by modulating synaptic activity (Lujan and Ciruela, <xref ref-type="bibr" rid="B37">2012</xref>).</p>
<p>In this study, we aimed to characterize A&#x003B2; effects on septohippocampal fimbria/CA3 synapsis. To address this question, we used an <italic>in vitro</italic> preparation taking advantage of the specific septo-hippocampal projection to CA3 pyramidal neurons, and evoked a characteristic complex synaptic response in CA3 recorded neurons by stimulating the septal part of the fimbria. For the first time, we provide evidence that A&#x003B2; decreased GABA<sub>B</sub> neurotransmission through altering GirK channel conductance.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Animals</title>
<p>Experiments were carried out on male and female rats (80&#x02013;100 g) raised in the Salamanca University Animal House (Salamanca, Spain). All animal procedures were reviewed and approved by the Ethical Committee for Use of Laboratory Animals of the University of Salamanca and University of Castilla-La Mancha, and followed the European Communities Council (86/609/EEC).</p>
</sec>
<sec>
<title>Preparation of slices</title>
<p>Animals were deeply anesthetized with halothane and decapitated. The brain was excised and rapidly immersed in oxygenated ice-cold (4&#x02013;6&#x000B0;C) artificial cerebrospinal fluid (ACSF), with sucrose (234 mM) replacing the NaCl (117 mM) to maintain osmolarity. In order to preserve the optimal connectivity from fimbria fibers on CA3 pyramidal neurons (Gloveli et al., <xref ref-type="bibr" rid="B25">2005</xref>; Bischofberger et al., <xref ref-type="bibr" rid="B5">2006</xref>), horizontal slices containing the septal part of the fimbria, i.e., lateral fimbria (Alonso and Kohler, <xref ref-type="bibr" rid="B1">1984</xref>; Amaral and Lavenex, <xref ref-type="bibr" rid="B2">2007</xref>), and the hippocampus (350 &#x003BC;m-thick) were cut in cold oxygenated Ringer solution using a vibratome (Leica VT 1000S, Wetzlar, Germany) and placed in an incubation chamber, where they were maintained for at least 2 h at room temperature (22&#x000B0;C) before the recordings. Further details of this <italic>in vitro</italic> preparation have been described elsewhere (Yajeya et al., <xref ref-type="bibr" rid="B80">2000</xref>).</p>
</sec>
<sec>
<title>Sharp electrode recordings</title>
<p>For recordings, a single septohippocampal slice was transferred to an interface recording chamber (BSC-HT and BSC-BU; Harvard Apparatus, Holliston, US) and perfused continuously with ACSF comprising (in mM) 117 NaCl, 4.7 KCl, 2.5 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 25 NaHCO<sub>3</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, and 11 glucose. The ACSF was bubbled with carbogen gas (95%O<sub>2</sub>&#x02013;5%CO<sub>2</sub>) and maintained at room temperature during the recordings.</p>
<p>Intracellular sharp electrode recordings from CA3 pyramidal neurons were obtained with borosilicate glass microelectrodes (140&#x02013;180 M&#x003A9;; WPI, Sarasota, US) filled with a potassium acetate solution (3 M) and connected to the headstage of an intracellular recording amplifier (Bio-logic VF180, Claix, France). Only data from neurons with both, stable resting membrane potential (RMP) with values &#x02264; &#x02212;60 mV in the absence of direct current (DC) holding currents, and presenting overshooting action potentials, were collected for analysis. Spike amplitude, afterdepolarization and afterhyperpolarizing potentials were measured relative to threshold.</p>
<p>Excitatory and inhibitory postsynaptic potentials (EPSP and IPSP, respectively) were elicited orthodromically by stimulating the lateral fimbria where septal afferents to CA3 hippocampal neurons are mainly found (Alonso and Kohler, <xref ref-type="bibr" rid="B1">1984</xref>; Amaral and Lavenex, <xref ref-type="bibr" rid="B2">2007</xref>). For that purpose a monopolar stainless steel electrode (2 M&#x003A9; of effective resistance; WPI, Sarasota, US) and a programmable stimulator (MASTER-8, A8, A.M.P.I., Jerusalem, Israel) were used. Single, cathodal, square-wave pulses of 100&#x02013;200 &#x003BC;s duration and 100&#x02013;500 &#x003BC;A intensity were adjusted to subthreshold values for orthodromic spike generation. Postsynaptic potentials were characterized according to their amplitude (as a function of the RMP) and latency. Since horizontal slices were obtained at different level and angle, sometimes the location of the electrode along lateral fimbria had to be changed to evoke the characteristic triphasic response.</p>
</sec>
<sec>
<title>Identification of stimulation and recording sites</title>
<p>Recorded neurons were identified following procedures described elsewhere (Navarro-Lopez et al., <xref ref-type="bibr" rid="B51">2004</xref>). Briefly, selected neurons were stained by the intracellular injection of biocytin diluted in a 2 M potassium acetate solution, using positive current pulses of 0.2 nA for 6 min. Slices were fixed, and cut in sections (40 &#x003BC;m) using a freezing microtome (HM400R, Microm, Heidelberg, Germany). Sections were incubated with avidin-biotin-peroxidase complex (ABC, Vector Labs., Burlingame, US). 3,3&#x02032;-Diaminobenzidine was used as chromogen for visualization of the biocytin complex. Sections were counterstained with cresyl violet. Neuron was reconstructed from serial sections using a graphic design software. Photographs were superimposed and orientated to obtain the best fit between the corresponding sectioned elements.</p>
</sec>
<sec>
<title>Drugs</title>
<p>All chemicals used in this study were purchased from Sigma (Poole, UK) and Tocris (Biogen Cient&#x000ED;fica, Spain) and applied by superfusion in the ACSF. The chemicals used were amyloid-&#x003B2; peptides (A&#x003B2;<sub>25&#x02013;35</sub> and the reverse A&#x003B2;<sub>35&#x02013;25</sub>), 6-cyano-nitroquinoxaline-2,3-dione (CNQX; a potent, competitive AMPA-kainate receptor antagonist), 2-amino-5-phosphonovalerate (APV; a specific blocker of NMDA receptors), Bicuculline Methiodide (specific blocker of GABA<sub>A</sub> receptors), (RS)-3-Amino-2-(4-chlorophenyl) propylphosphonic acid (Saclofen; blocker of GABA<sub>B</sub> receptors), (RS)-4-Amino-3-(4-chlorophenyl) butanoic acid (Baclofen; agonist of GABA<sub>B</sub> receptors), Tetrodotoxine (TTX; voltage dependent sodium channel blocker), Tertiapin-Q (selective blocker of GirK channels) and 2-methyl-2,4-pentanediol (MPD, agonist of GirK channels).</p>
</sec>
<sec>
<title>Preparation of A&#x003B2; peptides solutions</title>
<p>A&#x003B2;<sub>25&#x02013;35</sub> and A&#x003B2;<sub>35&#x02013;25</sub> peptides were prepared as previously (Ashenafi et al., <xref ref-type="bibr" rid="B4">2005</xref>; Santos-Torres et al., <xref ref-type="bibr" rid="B59">2007</xref>). Briefly, the peptides were dissolved to 1 mM in bidistilled water and stored in aliquots at &#x02212;20&#x000B0;C. Then aliquots were diluted in ACSF to required concentration and incubated for 24 h at 37&#x000B0;C before experiments were performed (Pe&#x000F1;a et al., <xref ref-type="bibr" rid="B55">2010</xref>; Leao et al., <xref ref-type="bibr" rid="B35">2012</xref>).</p>
</sec>
<sec>
<title>Data storage and statistical analysis</title>
<p>Sharp electrode data were acquired online with the help of a CED 1401 interface (CED, Cambridge, UK), and stored on a personal computer (sample frequency 12.5 kHz). Analysis in both cases was performed using the MiniAnalysis Program, version 6.0.3 (Synaptosoft, Decatur, US). Unless otherwise indicated, the electrophysiological data are always expressed as mean &#x000B1; standard error of the mean (SEM), and n represents the number of averaged neurons. Synaptic potentials were averaged (&#x02265;5) before quantitative analysis. Statistical analysis of collected data was performed using either Student&#x00027;s <italic>t</italic>-test or non-parametric test (Mann-Whitney <italic>U</italic>-test), accordingly with data distribution. When necessary, one-way ANOVA or equivalent non parametric test (Kruskal-Wallis test) and <italic>post-hoc</italic> analysis were performed. Statistical significance was determined at a level of <italic>p</italic> &#x02264; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Electrophysiological characterization of recorded neurons and their synaptic response to fimbria stimulation</title>
<p>This study comprises 110 intracellular recordings from pyramidal CA3 neurons (Figure <xref ref-type="fig" rid="F1">1</xref>), selected on the basis of their RMP (&#x02264; &#x02212;60 mV) and monosynaptic activation from the fimbria. Recorded neurons did not exhibit action potentials spontaneously at RMP values (&#x02212;72.5 &#x000B1; 1.8 mV). The input resistance (Ri) of the neurons was 113.4 &#x000B1; 6.7 M&#x003A9; and the membrane time constant was 77.2 &#x000B1; 25.4 ms. The direct activation of these neurons by depolarizing current injections (0.1&#x02013;0.6 nA ; 300 ms) evoked a series of two to five spikes with marked spike frequency adaptation and decreased amplitude and longer duration of the second spike relative to the first one (Figure <xref ref-type="fig" rid="F1">1B</xref>). The spike amplitude was 101.1 &#x000B1; 3.2 mV. These characteristics, together with neuronal morphology (Figure <xref ref-type="fig" rid="F1">1D</xref>) and other electrophysiological properties such as the presence of triphasic afterhyperpolarization (fAHP: 5.6 &#x000B1; 0.8 mV; mAHP: 10.5 &#x000B1; 1.5 mV; sAHP: 17.6 &#x000B1; 1.3 mV) or afterdepolarization (ADP: 3.6 &#x000B1; 0.5 mV), characterize the principal pyramidal-like neurons widely described in the hippocampus (Spruston and Johnston, <xref ref-type="bibr" rid="B65">1992</xref>; Wittner et al., <xref ref-type="bibr" rid="B78">2007</xref>). The location of selected neurons (<italic>n</italic> &#x0003D; 10) filled with biocytin is illustrated in Figure <xref ref-type="fig" rid="F1">1A</xref>. The morphology corresponds to pyramidal neurons in CA3 region of the hippocampus. The cell body is located into the <italic>stratum pyramidale</italic> and the visible basal dendrites on <italic>stratum oriens</italic> (Figure <xref ref-type="fig" rid="F1">1D</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Location and electrophysiological characterization of the recorded neurons in hippocampal slices. (A)</bold> Experimental design. Diagram of stimulation and recording sites in an hippocampal horizontal section. Schematic location of recording (Rec.) and stimulating (St.) electrodes is shown. Stimuli were applied to the lateral part of the fimbria (shaded area). <bold>(B)</bold> Response of a CA3 neuron to depolarizing pulses consisted of two to five spikes with marked spike frequency adaptation with a depolarizing current pulse (100 pA, 300 ms) while hyperpolarizing current pulse injection (&#x02212;160 pA, 300 ms) induced a hyperpolarizing response that allowed us monitoring the input resistance during the experiments. <bold>(C)</bold> Current-voltage (<italic>I</italic>-<italic>V</italic>) relationships for the pyramidal neuron recorded in <bold>(B)</bold>. <bold>(D)</bold> Reconstruction of the CA3 neuron recorded in <bold>(B,C)</bold> labeled with biocytin after intracellular recording from 40-&#x003BC;m-thick serial sections. Note the pyramidal morphology of the injected hippocampal cell. ori, <italic>stratum oriens</italic>; pyr, <italic>stratum pyramidale</italic>; luc, <italic>stratum lucidum</italic>; Scale bar 50 &#x003BC;m.</p></caption>
<graphic xlink:href="fncel-07-00117-g0001.tif"/>
</fig>
<p>Single subthreshold stimulation of the fimbria evoked stereotyped triphasic synaptic responses in CA3 pyramidal cells (Figure <xref ref-type="fig" rid="F2">2</xref>). The initial response was a fast EPSP, which occurred at a latency of 6.5 &#x000B1; 0.6 ms following stimulus offset, suggesting the monosynaptic nature of the connection. The size of the EPSP was graded with the stimulus intensity and it increased in amplitude when elicited at progressively more negative membrane potentials (Figure <xref ref-type="fig" rid="F2">2A</xref>). The EPSP was followed by a rapidly developing hyperpolarization (early IPSP, Figures <xref ref-type="fig" rid="F2">2A,B</xref>) that reached its peak amplitude 30.4 &#x000B1; 1.4 ms (<italic>n</italic> &#x0003D; 11) following fimbria stimulation. Finally a second hyperpolarization (late IPSP, Figures <xref ref-type="fig" rid="F2">2A,B</xref>) following the early IPSP, had a latency to peak amplitude of 247.4 &#x000B1; 6.6 ms (<italic>n</italic> &#x0003D; 44). The amplitudes of both, IPSPs and EPSP, varied with membrane potential (Figures <xref ref-type="fig" rid="F2">2A,B</xref>), allowing us to determine the approximate reversal potential for both inhibitory components (early &#x02212;61.1 mV and late &#x02212;80.0 mV).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Postsynaptic septohippocampal response in CA3 pyramidal neurons. (A)</bold> Effect of membrane potential variations on the amplitude of the early and late IPSPs evoked by orthodromic activation in a pyramidal CA3 neuron. Stimulation of the fimbria elicited an EPSP followed by an early (open circles) and late (closed circles) IPSP. Traces shown are the average of five responses. <bold>(B)</bold> Effect of varying the intensity of fimbria stimulation on the complex postsynaptic response recorded in another neuron at a membrane potential of &#x02212;60 mV. From top to bottom, traces represent synaptic responses which were evoked by progressive increments in fimbria stimulation. Stimulation of the fimbria at a low intensity evoked only EPSP followed by an early (&#x025E6;, open circles) IPSP. Delivery of stimulation at higher intensities resulted in the elicitation of a subsequent late (&#x02022;, closed circles) IPSP. The approximate reversal potential for both inhibitory components was early &#x02212;61.1 mV and late &#x02212;80.0 mV.</p></caption>
<graphic xlink:href="fncel-07-00117-g0002.tif"/>
</fig>
<p>In order to determine the nature of the complex response, a pharmacological dissection of the postsynaptic potential components was performed (Figure <xref ref-type="fig" rid="F3">3</xref>). The early IPSP was blocked by bicuculline (10 &#x003BC;M, <italic>n</italic> &#x0003D; 6), a specific blocker of GABA<sub>A</sub> receptors (Figures <xref ref-type="fig" rid="F3">3A,C&#x02013;E</xref>) whereas late IPSP was removed by saclofen (200 &#x003BC;M; <italic>n</italic> &#x0003D; 5), a specific blocker of GABA<sub>B</sub> receptors (Figures <xref ref-type="fig" rid="F3">3B,E</xref>). The excitatory component was increased by early IPSP block with bicuculline (<italic>n</italic> &#x0003D; 9; Figures <xref ref-type="fig" rid="F3">3A,C&#x02013;E</xref>) and presented a glutamatergic nature acting mainly on non-NMDA (<italic>n</italic> &#x0003D; 5; Figure <xref ref-type="fig" rid="F3">3D</xref>) receptors, since although its complete elimination required CNQX (10 &#x003BC;M) and APV (50 &#x003BC;M) the cells were held at &#x02212;75 mV (a membrane potential where NMDA receptor-mediated currents are null). However, when recorded cells were held at more positive values than RMP (<italic>n</italic> &#x0003D; 4; Figure <xref ref-type="fig" rid="F3">3C</xref>), NMDA channels were entirely functional and perfusion with APV decreased both bicuculline-enhanced responses, EPSP and late IPSP (Figure <xref ref-type="fig" rid="F3">3E</xref>), suggesting the participation of NMDA receptors in the response. As previously, complete blockage of EPSP also required CNQX (Figure <xref ref-type="fig" rid="F3">3C</xref>). In this regard, the pharmacological elimination of glutamatergic responses with CNQX plus APV also abolished the inhibitory response (Figures <xref ref-type="fig" rid="F3">3C,D</xref>) suggesting that IPSPs were produced by interneurons activation.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Pharmacological characterization of septohippocampal synaptic response. (A)</bold> Recordings from a pyramidal CA3 neuron illustrating a marked reduction of the early IPSP after perfusion with bicuculline (10 &#x003BC;M; specific blocker of GABA<sub>A</sub> receptors). <bold>(B)</bold> Blocking of the late IPSP after perfusion with saclofen (200 &#x003BC;M; blocker of GABA<sub>B</sub> receptor) was accompanied by a mild increase of the early IPSP and EPSP. <bold>(C)</bold> The increase in the amplitude of EPSP and late IPSP produced by perfusion of bicuculline was reduced by APV application (50 &#x003BC;M; specific blocker of NMDA receptor). Membrane potential was maintained at values more positives than resting membrane potential to assure NMDA receptors functionality. Synaptic response was completely removed with the addition of CNQX (10 &#x003BC;M; competitive non-NMDA receptor antagonist). <bold>(D)</bold> Blockade of the early IPSP with bicuculline (<italic>n</italic> &#x0003D; 4) was associated with a marked increase in amplitude of EPSP and late IPSP. Excitatory and inhibitory responses were blocked by CNQX and APV. The cells were held at &#x02212;75 mV (a membrane potential where NMDA receptor-mediated currents are null). <bold>(E)</bold> Histograms with relative mean amplitude as percentage of control of the different components of the complex synaptic response (EPSP; early, e.IPSP; and late, l.IPSP) under pharmacological conditions described in <bold>(A&#x02013;D)</bold> (<sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001). <bold>(F)</bold> Both, early and late IPSPs were blocked by bicuculline and saclofen, respectively, while a large repetitive burst of action potential appeared (<italic>n</italic> &#x0003D; 4). At membrane potential values that assured NMDA activation, this epileptic-like activity could be removed by CNQX. Finally, residual excitatory NMDA response was eliminated by APV perfusion. <bold>(G)</bold> During the epileptic-like activity induced by both inhibitory components elimination, and at membrane potential values that led NMDA receptor activation, APV perfusion reduced the size of the epileptic response that had to be removed by addition of CNQX (<italic>n</italic> &#x0003D; 4).</p></caption>
<graphic xlink:href="fncel-07-00117-g0003.tif"/>
</fig>
<p>On the other hand, when both inhibitory components were removed an epileptiform-like discharge was generated (Figures <xref ref-type="fig" rid="F3">3F,G</xref>). This response could reach a firing frequency of 90 Hz and showed a glutamatergic nature acting mainly on non-NMDA receptors, since CNQX completely abolished it (Figure <xref ref-type="fig" rid="F3">3F</xref>) whereas APV only could block it partially (Figure <xref ref-type="fig" rid="F3">3G</xref>).</p>
<p>These results indicate that the triphasic complex response involves excitatory and inhibitory neurotransmission mediated by glutamate and GABA receptors activation, suggesting that a precise tuning is required for information processing at this synapse.</p>
</sec>
<sec>
<title>A&#x003B2;<sub>25&#x02013;35</sub> differential effects on membrane properties</title>
<p>In all cases, the recordings were stabilized for at least 10 min. During this time, characterization of firing pattern, membrane potential, Ri and synaptic responses were performed. The specificity of the A&#x003B2;<sub>25&#x02013;35</sub> peptide action was confirmed by the use, as negative control, of the reverse sequence A&#x003B2;<sub>35&#x02013;25</sub> (1.5 &#x003BC;M), without any noticeable effect (Figures <xref ref-type="fig" rid="F4">4A,C</xref>). Then, slices were perfused with increasing concentrations of A&#x003B2;<sub>25&#x02013;35</sub> (0.5, 1.0, and 1.5 &#x003BC;M) for at least another 10 min at each concentration.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Effects of A&#x003B2;<sub>25&#x02013;35</sub> on membrane potential and Ri of CA3 neurons. (A)</bold> Recording of a CA3 pyramidal neuron during the perfusion of the reverse sequence of the peptide, A&#x003B2;<sub>35&#x02013;25</sub>, used as negative control (<italic>n</italic> &#x0003D; 4). <bold>(B)</bold> Depolarization of membrane potential induced by perfusion of A&#x003B2; in a recorded pyramidal CA3 neuron (<italic>n</italic> &#x0003D; 10). <bold>(C)</bold> Plot of the membrane potential variations as a percentage of resting membrane potential (RMP). Perfusion of A&#x003B2;<sub>35&#x02013;25</sub> 1 &#x003BC;M or A&#x003B2;<sub>25&#x02013;35</sub> 0.5 &#x003BC;M did not induce any significant change in the membrane potential or Ri. A&#x003B2;<sub>25&#x02013;35</sub> higher concentrations induced the cells to depolarize (1 &#x003BC;M; 6.8 &#x000B1; 3.2 %, <italic>n</italic> &#x0003D; 4; 1.5 &#x003BC;M, 8.6 &#x000B1; 2.2 %, <italic>n</italic> &#x0003D; 10). <bold>(D1)</bold> Time course of A&#x003B2; effects on Ri in a CA3 pyramidal neuron after perfusion with TTX. The membrane potential was held at its RMP value by direct current (DC) holding current injection to cancel out the depolarization. <bold>(D2)</bold> For the same neuron, each point represents the Ri during the recording in <bold>(D1)</bold>. Membrane potential was held at &#x02212;71 mV. <bold>(E)</bold> Plot showing the time course of the effects of A&#x003B2;<sub>25&#x02013;35</sub> concentration increase on the Ri of a CA3 pyramidal neuron. Note that recordings last for a very long time. <bold>(F)</bold> Histogram with mean values in percentage for Ri (<italic>n</italic> &#x0003D; 10) at different A&#x003B2;<sub>25&#x02013;35</sub> concentration (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fncel-07-00117-g0004.tif"/>
</fig>
<p>No significant differences were found in spike amplitude [<italic>F</italic><sub>(3, 50)</sub> &#x0003D; 2.62, <italic>p</italic> &#x0003D; 0.062], threshold [<italic>F</italic><sub>(3, 50)</sub> &#x0003D; 2.14, <italic>p</italic> &#x0003D; 0.108], ADP [<italic>F</italic><sub>(3, 22)</sub> &#x0003D; 0.576, <italic>p</italic> &#x0003D; 0.638], fAHP [<italic>F</italic><sub>(3, 31)</sub> &#x0003D; 1.22, <italic>p</italic> &#x0003D; 0.320], or sAHP [<italic>F</italic><sub>(3, 33)</sub> &#x0003D; 1.625, <italic>p</italic> &#x0003D; 0.204] after perfusion with A&#x003B2;<sub>25&#x02013;35</sub> at increasing concentrations. However, as shown in Figures <xref ref-type="fig" rid="F4">4B,C</xref>, a significant depolarization was observed when A&#x003B2;<sub>25&#x02013;35</sub> was applied (1 &#x003BC;M; 4.3 &#x000B1; 2.3 mV; <italic>n</italic> &#x0003D; 4; and 1.5 &#x003BC;M; 6.2 &#x000B1; 1.6 mV; <italic>n</italic> &#x0003D; 10). The membrane potential of the recorded neurons was maintained at its RMP value by DC holding current injection to cancel out the depolarization induced by A&#x003B2;<sub>25&#x02013;35</sub> (Figure <xref ref-type="fig" rid="F4">4D</xref>). These variations in current injection were statistically significant at 1.0 &#x003BC;M (<italic>t</italic> &#x0003D; 2.557, <italic>p</italic> &#x0003D; 0.021) and 1.5 &#x003BC;M (<italic>t</italic> &#x0003D; 4.301, <italic>p</italic> &#x0003C; 0.001) concentrations and no difference was observed at 0.5 &#x003BC;M concentrations (<italic>t</italic> &#x0003D; 0.842, <italic>p</italic> &#x0003D; 0.412). Additionally, A&#x003B2;<sub>25&#x02013;35</sub> also produced a significant increase in the relative Ri (% &#x0003D; Ri recorded/Ri control <sup>&#x0002A;</sup>100; <italic>n</italic> &#x0003D; 16) (Figures <xref ref-type="fig" rid="F4">4D&#x02013;F</xref>) at 1.0 &#x003BC;M concentration (<italic>t</italic> &#x0003D; &#x02212;2.635, <italic>p</italic> &#x0003D; 0.018) and 1.5 &#x003BC;M (<italic>t</italic> &#x0003D; &#x02212;3.236, <italic>p</italic> &#x0003D; 0.007) whereas no differences were found at 0.5 &#x003BC;M (Mann&#x02013;Whitney U Statistic &#x0003D; 10.000, <italic>p</italic> &#x0003D; 0.690) (Figures <xref ref-type="fig" rid="F4">4E,F</xref>).</p>
<p>To determine the synaptic location of these A&#x003B2;<sub>25&#x02013;35</sub> effects, slices were perfused with TTX and any afferent synaptic activity was blocked. In these conditions, superfusion of the slice with A&#x003B2;<sub>25&#x02013;35</sub> was able to evoke both, depolarization and Ri increasing (Figure <xref ref-type="fig" rid="F4">4D</xref>) of intracellularly recorded CA3 pyramidal neurons, suggesting a postsynaptic location for the A&#x003B2;<sub>25&#x02013;35</sub> action mechanism (<italic>n</italic> &#x0003D; 5).</p>
</sec>
<sec>
<title>Differential effects of A&#x003B2;<sub>25&#x02013;35</sub> on fimbria-CA3 synaptic response</title>
<p>Since A&#x003B2; has widely shown to exert its effects through septohippocampal network impairing, we examined whether this peptide altered the fimbria-CA3 complex postsynaptic response (<italic>n</italic> &#x0003D; 20). In the experiment shown in Figure <xref ref-type="fig" rid="F5">5A</xref>, superfusion of A&#x003B2;<sub>25&#x02013;35</sub> produced a significant decrease of the late IPSP component (1 &#x003BC;M; <italic>t</italic> &#x0003D; 2.532, <italic>p</italic> &#x0003D; 0.030 and 1.5 &#x003BC;M; <italic>t</italic> &#x0003D; 2.519, <italic>p</italic> &#x0003D; 0.036) that was neither observed at 0.5 &#x003BC;M (<italic>t</italic> &#x0003D; 1.133, <italic>p</italic> &#x0003D; 0.295) nor on early IPSP (<italic>H</italic> &#x0003D; 2.578; <italic>p</italic> &#x0003D; 0.461). However, the late IPSP reduction was associated with an increase in the excitatory response observed at concentration of 1.5 &#x003BC;M (<italic>t</italic> &#x0003D; &#x02212;2.503, <italic>p</italic> &#x0003D; 0.046) but not at lower concentrations (Figures <xref ref-type="fig" rid="F5">5B,C</xref>). These results indicate a possible mechanism to imbalance the particular excitatory/inhibitory tuning in the septohippocampal system, and therefore a differential A&#x003B2;<sub>25&#x02013;35</sub> effect, according to the specific neurotransmission system involved.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Selective effect of A&#x003B2;<sub>25&#x02013;35</sub> on different components of the complex postsynaptic response recorded in CA3 pyramidal neurons by fimbria stimulation. (A)</bold> Evoked responses obtained in a pyramidal CA3 neuron by fimbria orthodromic stimulation (control) and during perfusion of different concentrations of A&#x003B2;<sub>25&#x02013;35</sub> (0.5, 1, and 1.5 &#x003BC;M). The reduction of the late IPSP after perfusion with A&#x003B2;<sub>25&#x02013;35</sub> has been shown to be concentration-dependent. <bold>(B)</bold> Plot displaying the time course of A&#x003B2;<sub>25&#x02013;35</sub> perfusion effects on the amplitude (in mV) of the different components of the complex response (EPSP, black diamonds; early IPSP, gray squares; late IPSP, white triangles; see color code in <bold>C</bold>). <bold>(C)</bold> Histograms with relative mean amplitude (<italic>n</italic> &#x0003D; 20) of the different components of the complex synaptic response (EPSP; early, e.IPSP; and late, l.IPSP) 10 min after A&#x003B2;<sub>25&#x02013;35</sub> perfusion (0.5, 1, and 1.5 &#x003BC;M). Significant differences were found for EPSP at 1.5 &#x003BC;M A&#x003B2;<sub>25&#x02013;35</sub> and for late IPSP at 1&#x02013;1.5 &#x003BC;M A&#x003B2;<sub>25&#x02013;35</sub>. <bold>(D)</bold> Correlation analysis of A&#x003B2;<sub>25&#x02013;35</sub> perfusion on different components of the complex postsynaptic response vs. Ri values. Data showed a higher correlation between A&#x003B2;-induced Ri increase and late IPSP amplitude (<italic>R</italic> &#x0003D; &#x02212;0.73, <italic>p</italic> &#x0003C; 0.001; <bold>D3</bold>) than A&#x003B2;-induced Ri increase and EPSP (<italic>R</italic> &#x0003D; 0.42, <italic>p</italic> &#x0003C; 0.001; <bold>D1</bold>) or early IPSP (<italic>R</italic> &#x0003D; 0.31, <italic>p</italic> &#x0003C; 0.01; <bold>D2</bold>)(<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05; <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fncel-07-00117-g0005.tif"/>
</fig>
<p>Due to this differential A&#x003B2;<sub>25&#x02013;35</sub> effect on both inhibitory components, the late component reduction may not be attributable to a decreased neurotransmitter release since GABA<sub>A</sub> component amplitude was maintained. This result pointed out to a selective postsynaptic action on GABA<sub>B</sub> complex.</p>
</sec>
<sec>
<title>A&#x003B2;<sub>25&#x02013;35</sub> effects can be explained by a reduction in the conductance of GirK channels coupled to GABA<sub>B</sub> receptor</title>
<p>Depolarization caused by A&#x003B2;<sub>25&#x02013;35</sub> was associated to Ri increase and therefore, linked to a possible decrease in membrane conductance, which may very likely involve in ion channels closing. Given the correlation between reduction in GABA<sub>B</sub> component and Ri increase shown in Figure <xref ref-type="fig" rid="F5">5D</xref>, we investigated whether these A&#x003B2;<sub>25&#x02013;35</sub> effects could be mediated by conductance reduction of GABA<sub>B</sub> effector, GirK channel. We found that GirK blockade by its selective antagonist, tertiapin-Q (0.5 &#x003BC;M), not only removed the GABA<sub>B</sub> component (late IPSP; Figures <xref ref-type="fig" rid="F6">6A,B</xref>) of the synaptic response, but also induced a significant increase in Ri (Figures <xref ref-type="fig" rid="F6">6C,D</xref>; 122.5 &#x000B1; 5.4%; <italic>t</italic> &#x0003D; &#x02212;3.264; <italic>p</italic> &#x0003D; 0.022) as well as membrane depolarization (Figure <xref ref-type="fig" rid="F6">6E</xref>; 9.1 &#x000B1; 2.6 mV; <italic>n</italic> &#x0003D; 5; <italic>t</italic> &#x0003D; 8.69, <italic>p</italic> &#x0003C; 0.001), therefore mimicking all A&#x003B2;<sub>25&#x02013;35</sub> effects previously described.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Effects of the selective GirK channel antagonist tertiapin-Q on CA3 pyramidal neurons complex response to fimbria stimulation. (A)</bold> Selective blockade by tertiapin-Q of the late IPSP recorded in CA3 pyramidal neurons after fimbria stimulation. Superfusion of the GirK antagonist tertiapin-Q (0.5 &#x003BC;M; selective blocker of GirK channels) selectively blocked the late IPSP but did not reduce the early IPSP that was elicited by fimbria stimulation. <bold>(B)</bold> Histograms with relative mean amplitude (<italic>n</italic> &#x0003D; 5) of the different components of the complex synaptic response (EPSP; early, e.IPSP; and late, l.IPSP) 40 min after tertiapin-Q perfusion. Significant differences were found for late IPSP. <bold>(C)</bold> Results of an experiment in another neuron designed to assess the postsynaptic effects of tertiapin-Q on Ri of CA3 pyramidal neurons. Perfusion of TTX (<italic>n</italic> &#x0003D; 5; 1 &#x003BC;M; voltage-dependent sodium channel blocker) blocked afferent neurotransmission and therefore any effect of tertiapin-Q took place at postsynaptic location. Note the significant Ri increase after 30 min. <bold>(D)</bold> Histogram with mean values in percentage for Ri (<italic>n</italic> &#x0003D; 6) after tertiapin-Q perfusion during 40 min (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05). <bold>(E)</bold> Effect of tertiapin-Q on CA3 pyramidal neurons membrane potential (<italic>n</italic> &#x0003D; 5). Chart record shows that superfusion of tertiapin-Q (0.5 &#x003BC;M) produced a marked depolarization when applied at resting membrane potential (&#x02212;65 mV). <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C;0.01.</p></caption>
<graphic xlink:href="fncel-07-00117-g0006.tif"/>
</fig>
<p>To determine the mechanism involved in the postsynaptic reduction of the late IPSP amplitude and Ri increase, pharmacological blockage of different receptors/channels was performed and effects of increasing A&#x003B2;<sub>25&#x02013;35</sub> concentrations on Ri were evaluated (Figure <xref ref-type="fig" rid="F7">7</xref>). The blockade of synaptic transmission by TTX did not produce significant changes in Ri (Mann-Whitney U, <italic>p</italic> &#x0003D; 0.700) compared to control (Figures <xref ref-type="fig" rid="F7">7A&#x02013;C</xref>, Exp. 1&#x02013;3). Then, A&#x003B2;<sub>25&#x02013;35</sub> perfusion produced a significant increase in Ri (<italic>n</italic> &#x0003D; 4) at high concentrations (Figure <xref ref-type="fig" rid="F7">7</xref>, Exp. 1; 1.0 &#x003BC;M, <italic>t</italic> &#x0003D; &#x02212;7.424; <italic>p</italic> &#x0003D; 0.018 and 1.5 &#x003BC;M, <italic>t</italic> &#x0003D; &#x02212;7.519; <italic>p</italic> &#x0003D; 0.002), which was not observed at 0.5 &#x003BC;M (Mann-Whitney U, <italic>p</italic> &#x0003D; 1.00). These results indicate a postsynaptic A&#x003B2;<sub>25&#x02013;35</sub> mechanism that quite likely involves a reduction in ion channels conductance.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>Histograms with Ri mean values in CA3 pyramidal neurons for increasing A&#x003B2;<sub>25&#x02013;35</sub> concentrations. (A)</bold> Normalized mean value of Ri as % of control after perfusion with three different A&#x003B2;<sub>25&#x02013;35</sub> concentrations in three different experimental conditions (Exp. 1&#x02013;3). In all cases, TTX pre-treatment (1 &#x003BC;M; voltage-dependent sodium channel blocker) was unable to prevent A&#x003B2;<sub>25&#x02013;35</sub> effects on Ri, suggesting a postsynaptic location for A&#x003B2;<sub>25&#x02013;35</sub> action. Exp. 1: Significant increase on Ri was recorded after 1 and 1.5 &#x003BC;M A&#x003B2;<sub>25&#x02013;35</sub> perfusion (<italic>n</italic> &#x0003D; 16), even in the presence of TTX. Exp. 2: After perfusion of both TTX and saclofen (to block postsynaptic GABA<sub>B</sub> receptors), A&#x003B2;<sub>25&#x02013;35</sub> was unable to evoke any significant modification in Ri (<italic>n</italic> &#x0003D; 6). Exp. 3: As in the experiment showed in Figure <xref ref-type="fig" rid="F6">6B</xref>, TTX perfusion together with the selective antagonist of GirK channels, tertiapin-Q (0.5 &#x003BC;M), induced a significant increase in Ri compared to control values. However, when tertiapin-Q was perfused and GirK channels blocked, A&#x003B2;<sub>25&#x02013;35</sub> became unable to induce any additional Ri increase (<italic>n</italic> &#x0003D; 6). Control value for Ri was normalized to 100%. Data show mean &#x000B1; SEM. <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05. Lower-case letters (<italic>a&#x02013;e</italic>) indicate the five pharmacological conditions during each experimental treatment. <bold>(B)</bold> Representative examples for time course of Ri recorded in experimental conditions (Exp. 1&#x02013;3). The arrows indicate the time point at which drugs were applied during the recordings. <bold>(C)</bold> Representative examples of recordings were expanded in time to show the changes in membrane potential during the presentation of hyperpolarizing pulses. This protocol allowed us to monitor Ri during the whole recording and to study the effect of different pharmacological treatments represented by lower-case letters (<italic>a&#x02013;e</italic>).</p></caption>
<graphic xlink:href="fncel-07-00117-g0007.tif"/>
</fig>
<p>On the other hand, since saclofen perfusion prevented A&#x003B2;<sub>25&#x02013;35</sub>-induced changes on Ri (<italic>n</italic> &#x0003D; 6; <italic>H</italic> &#x0003D; 3.964, <italic>p</italic> &#x0003D; 0.411; Figure <xref ref-type="fig" rid="F7">7</xref>, Exp. 2), an interaction with GABA<sub>B</sub> receptors might be assumed. However, although saclofen also induced a reduction on late IPSP amplitude (see Figures <xref ref-type="fig" rid="F3">3B,E</xref>), in the presence of TTX it did not exhibit any noticeable effect on membrane potential (1.7 &#x000B1; 2.8 mV; <italic>t</italic> &#x0003D; &#x02212;0.541; <italic>p</italic> &#x0003D; 0.617; non illustrated) or Ri (Figure <xref ref-type="fig" rid="F7">7</xref>, Exp. 2; 94.5 &#x000B1; 7.3%; <italic>t</italic> &#x0003D; 1.198; <italic>p</italic> &#x0003D; 0.285), in contrast to A&#x003B2;<sub>25&#x02013;35</sub>. Altogether, these results suggest that A&#x003B2;<sub>25&#x02013;35</sub> exerts its effects acting preferentially on postsynaptic GirK channels, instead of GABA<sub>B</sub> receptors.</p>
<p>In accordance with this hypothesis, A&#x003B2;<sub>25&#x02013;35</sub> was found to be unable to generate additional increase on Ri after postsynaptic blockage of GirK channels by tertiapin-Q [Figure <xref ref-type="fig" rid="F7">7</xref>, Exp. 3; <italic>n</italic> &#x0003D; 6; <italic>F</italic><sub>(3, 21)</sub> &#x0003D; 0.129, <italic>p</italic> &#x0003D; 0.941], suggesting that A&#x003B2;-induced Ri increase may be associated to a reduction in GirK channel conductance. However, because conductance depends, among others, on the number of channels, their open probability or membrane voltage, the methodology used in the present study has some limitations to determine the exact mechanism for A&#x003B2;-mediated Ri increase. In addition, in some experiments, it was necessary to inject DC to maintain a stable membrane potential and to prevent depolarization. Previous studies had reported that depolarization mechanisms induced by A&#x003B2; might involve activation of glutamatergic receptors (Blanchard et al., <xref ref-type="bibr" rid="B6">2002a</xref>,<xref ref-type="bibr" rid="B7">b</xref>). In order to control these variables, tertiapin-Q was perfused together with glutamatergic antagonists CNQX (10 &#x003BC;M) and APV (50 &#x003BC;M). This protocol not only prevented the A&#x003B2;-mediated increase in Ri, but also abolished the dependence of DC injection to compensate membrane depolarization (<italic>n</italic> &#x0003D; 4; H &#x0003D; 3.709, <italic>p</italic> &#x0003D; 0.447; non illustrated). In contrast, perfusion with CNQX, APV and the GABA<sub>A</sub> blocker, bicuculline (10 &#x003BC;M), was not able to prevent the Ri increase induced by A&#x003B2;<sub>25&#x02013;35</sub> (<italic>n</italic> &#x0003D; 4; H &#x0003D; 21.681; <italic>p</italic> &#x0003C; 0.001; non illustrated) further suggesting an effect of A&#x003B2;<sub>25&#x02013;35</sub> on GirK channels.</p>
</sec>
<sec>
<title>Effects of A&#x003B2;<sub>25&#x02013;35</sub> on the hyperpolarization mediated by GABA<sub>B</sub>-GirK activation</title>
<p>Given that, Ri changes may depend on multiple factors and might be affected by A&#x003B2; acting on different ion channels and receptors, we designed a protocol to specifically evaluate the effects of A&#x003B2;<sub>25&#x02013;35</sub> on GABA<sub>B</sub> response. To verify whether A&#x003B2;<sub>25&#x02013;35</sub> affects the postsynaptic response mediated by GABA<sub>B</sub> receptor activation, we used a drug cocktail including: TTX to block synaptic transmission, bicuculline to block GABA<sub>A</sub> receptors activation and baclofen to stimulate GABA<sub>B</sub> receptors (Figure <xref ref-type="fig" rid="F8">8</xref>). Cocktail application in the slice produced a postsynaptic membrane hyperpolarization in recorded CA3 pyramidal neurons (Figures <xref ref-type="fig" rid="F8">8A,D</xref>; &#x02212;9.5 &#x000B1; 2.8% of the RMP value). When membrane potential was stabilized, A&#x003B2;<sub>25&#x02013;35</sub> perfusion induced a pronounced depolarization (Figures <xref ref-type="fig" rid="F8">8A,D</xref>; 15.5 &#x000B1; 4.3 % of the RMP value; <italic>n</italic> &#x0003D; 4), which confirms that A&#x003B2;<sub>25&#x02013;35</sub> reduces the postsynaptic GABA<sub>B</sub> response in a concentration and time dependent manner. But A&#x003B2;<sub>25&#x02013;35</sub> action on this GABA<sub>B</sub> response might also be explained by an effect on its final effector, GirK, which would also underlie the already described A&#x003B2;<sub>25&#x02013;35</sub> effects on Ri and membrane depolarization.</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p><bold>Effects of A&#x003B2;<sub>25&#x02013;35</sub> on postsynaptic hyperpolarization induced by activation of GABA<sub>B</sub> receptors. (A)</bold> Membrane potential recording from a CA3 neuron (top) after perfusion with TTX (1 &#x003BC;M; voltage-dependent sodium channels blocker), bicuculline (10 &#x003BC;M; specific blocker of GABA<sub>A</sub> receptor) and baclofen (15 &#x003BC;M; agonist of GABA<sub>B</sub> receptor). This treatment (<italic>n</italic> &#x0003D; 4) produced a membrane hyperpolarization depending on GABA<sub>B</sub> postsynaptic receptors activation. Perfusion with A&#x003B2;<sub>25&#x02013;35</sub> (1 and 1.5 &#x003BC;M) markedly induced the membrane to depolarize. <bold>(B)</bold> Intracellular hyperpolarizing current pulses. The arrows indicate the time points at which recordings were expanded in time to show the changes in the membrane potential during the presentation of hyperpolarizing pulses. This protocol allowed us to monitor Ri during the whole recording and check the viability of the neurons. Dashed lines in <bold>(A)</bold> and <bold>(B)</bold> indicate membrane resting potential. Maximum membrane potential evoked by A&#x003B2;<sub>25&#x02013;35</sub> superfusion is indicated by dotted lines. <bold>(C)</bold> In the same neuron, fimbria stimulation elicited the characteristic triphasic postsynaptic response before drugs cocktail perfusion. This complex postsynaptic potential was completely removed by TTX (1 &#x003BC;M; voltage-dependent sodium channels blocker) perfusion. <bold>(D)</bold> Plot of the membrane potential variations as a percentage of resting membrane potential (RMP) under pharmacological conditions presented in <bold>(A)</bold>. TTX, bicuculline and baclofen (drug cocktail) induced pyramidal neurons to hyperpolarize while A&#x003B2;<sub>25&#x02013;35</sub> produced a noticeable depolarization (<italic>n</italic> &#x0003D; 4; 21.4 &#x000B1; 5.9 mV). <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fncel-07-00117-g0008.tif"/>
</fig>
<p>In order to validate this hypothesis and evaluate the effect of A&#x003B2;<sub>25&#x02013;35</sub> on GirK response, we used a GirK channel agonist, MPD (Aryal et al., <xref ref-type="bibr" rid="B3">2009</xref>). Bath application of the previous drugs cocktail together with MPD (50 mM) induced the cell to hyperpolarize by two postsynaptic mechanisms, GABA<sub>B</sub> receptor activation and direct increase in GirK conductance (Figure <xref ref-type="fig" rid="F9">9</xref>; &#x02212;11.2 &#x000B1; 3.8% of the RMP value; <italic>n</italic> &#x0003D; 15). Then, perfusion of A&#x003B2;<sub>25&#x02013;35</sub> (1&#x02013;1.5 &#x003BC;M) removed the hyperpolarization mediated by GABA<sub>B</sub>-GirK stimulation (Figures <xref ref-type="fig" rid="F9">9A,E</xref>; 5.9 &#x000B1; 2.7%; <italic>n</italic> &#x0003D; 3, Figures <xref ref-type="fig" rid="F9">9B,E</xref>; 4.2 &#x000B1; 2.4%, <italic>n</italic> &#x0003D; 4), while this effect was not evident at 0.5 &#x003BC;M (Figures <xref ref-type="fig" rid="F9">9C,E</xref>; &#x02212;7.2 &#x000B1; 4.8% <italic>n</italic> &#x0003D; 4). In fact, the hyperpolarization could be eliminated when the cocktail was washed (Figure <xref ref-type="fig" rid="F9">9C</xref>). Finally, A&#x003B2;-induced depolarization was mimicked by tertiapin-Q, the specific antagonist of GirK channels (Figures <xref ref-type="fig" rid="F9">9D,E</xref>; 5.5 &#x000B1; 1.5%; <italic>n</italic> &#x0003D; 4), indicating that A&#x003B2;<sub>25&#x02013;35</sub> directly affects GirK channels conductance.</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p><bold>Effects of A&#x003B2;<sub>25&#x02013;35</sub> perfusion on the response evoked by pharmacological co-activation of GirK channels and GABA<sub>B</sub> receptors. (A,B)</bold> GirK/GABA<sub>B</sub> postsynaptic hyperpolarization was induced (<italic>n</italic> &#x0003D; 15) by perfusion of drugs cocktail including TTX (1 &#x003BC;M; voltage-dependent sodium channels blocker), bicuculline (10 &#x003BC;M; specific blocker of GABA<sub>A</sub> receptors), baclofen (15 &#x003BC;M; agonist of GABA<sub>B</sub> receptors), and MPD (50 mM; GirK channel agonist) perfusion. A&#x003B2;<sub>25&#x02013;35</sub> 1.5 &#x003BC;M (<italic>n</italic> &#x0003D; 3) and 1.0 &#x003BC;M (<italic>n</italic> &#x0003D; 4)(<bold>A</bold> and <bold>B</bold>, respectively) evoked a postsynaptic depolarization. <bold>(C)</bold> Using the same protocol, A&#x003B2;<sub>25&#x02013;35</sub> 0.5 &#x003BC;M was not able to produce this depolarization. The cocktail hyperpolarizing effect on membrane potential disappeared after cell washing with bathing solution (<italic>n</italic> &#x0003D; 4). <bold>(D)</bold> Tertiapin-Q (<italic>n</italic> &#x0003D; 4; 0.5 &#x003BC;M; selective blocker of GirK channels), the specific antagonist of GirK channels, induced a depolarization of the postsynaptic hyperpolarization mediated by GirK/GABA<sub>B</sub> activation, reproducing A&#x003B2;<sub>25&#x02013;35</sub> effects. <bold>(E)</bold> Plot showing the membrane potential changes as a percentage of resting membrane potential (RMP) under pharmacological conditions presented in <bold>(A&#x02013;D)</bold>. <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fncel-07-00117-g0009.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Despite the importance that rhythms as an emergent property of neural network seem to have, few studies have investigated how A&#x003B2; induces injury and how it may contribute to impair septohippocampal oscillatory activity, which in turn may underlie the early symptoms typically observed in AD patients (Colom, <xref ref-type="bibr" rid="B18">2006</xref>; Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>; Villette et al., <xref ref-type="bibr" rid="B72">2010</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>; Verret et al., <xref ref-type="bibr" rid="B70">2012</xref>). The present study identifies alterations in GirK channels conductance of fimbria-CA3 synapse as a putative mechanism of A&#x003B2;-induced synaptic dysfunction observed in the septohippocampal system activity.</p>
<sec>
<title>Septohippocampal system and A&#x003B2;<sub>25&#x02013;35</sub> neurotoxicity</title>
<p>Previously, it has been proposed that A&#x003B2;<sub>25&#x02013;35</sub> constitutes the biologically active fragment of A&#x003B2; (Millucci et al., <xref ref-type="bibr" rid="B47">2010</xref>), and has been shown to induce major neuropathological signs related to early stages of AD in rats (Klementiev et al., <xref ref-type="bibr" rid="B31">2007</xref>). In addition, A&#x003B2;<sub>25&#x02013;35</sub> is reported to be more soluble and presents toxic effects more rapidly than the parent peptide A&#x003B2;<sub>1&#x02013;42</sub> (Varadarajan et al., <xref ref-type="bibr" rid="B69">2001</xref>), and has widely been used as a very useful tool to explore acutely the pathophysiological events related with neuronal dysfunction induced by soluble A&#x003B2; forms (Ashenafi et al., <xref ref-type="bibr" rid="B4">2005</xref>; Santos-Torres et al., <xref ref-type="bibr" rid="B59">2007</xref>; Pe&#x000F1;a et al., <xref ref-type="bibr" rid="B55">2010</xref>; Leao et al., <xref ref-type="bibr" rid="B35">2012</xref>). But the most important advantage for present work is that A&#x003B2;<sub>25&#x02013;35</sub> does not form ion-permeable pores in neuronal membrane (Jang et al., <xref ref-type="bibr" rid="B29">2010</xref>; Chang et al., <xref ref-type="bibr" rid="B14">2011</xref>; Leao et al., <xref ref-type="bibr" rid="B35">2012</xref>) which could alter our protocols, especially input resistance measurements.</p>
<p>From neuroanatomical and electrophysiological points of view, hippocampus receives different projections from the medial septum diagonal broca band mainly through lateral fimbria (Wyss et al., <xref ref-type="bibr" rid="B79">1980</xref>; Alonso and Kohler, <xref ref-type="bibr" rid="B1">1984</xref>; Colom, <xref ref-type="bibr" rid="B18">2006</xref>; Amaral and Lavenex, <xref ref-type="bibr" rid="B2">2007</xref>). Cholinergic neurons innervate pyramidal neurons and interneurons (Widmer et al., <xref ref-type="bibr" rid="B77">2006</xref>), GABAergic fibers project onto interneurons (Freund and Antal, <xref ref-type="bibr" rid="B24">1988</xref>; Chamberland et al., <xref ref-type="bibr" rid="B13">2010</xref>) and glutamatergic projections contact with CA3 pyramidal cells (Huh et al., <xref ref-type="bibr" rid="B28">2010</xref>). These septo-hippocampal circuits are involved in both, generating hippocampal <italic>theta</italic> rhythm, as well as in learning and memory processes. To maintain these high-level functions, a precise septohippocampal network activity requires of finely regulated excitatory and inhibitory neurotransmission (Buzsaki, <xref ref-type="bibr" rid="B12">2002</xref>; Sotty et al., <xref ref-type="bibr" rid="B63">2003</xref>; Borhegyi et al., <xref ref-type="bibr" rid="B10">2004</xref>; Colom, <xref ref-type="bibr" rid="B18">2006</xref>) whose alteration could lead to impairments that would be consistent with the deficits described for AD initial stages (Bland and Colom, <xref ref-type="bibr" rid="B8">1993</xref>; Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>). In this sense, it has been reported that in hippocampus, A&#x003B2; mainly induces aberrant inhibitory septohippocampal network activity (Palop et al., <xref ref-type="bibr" rid="B53">2007</xref>; Villette et al., <xref ref-type="bibr" rid="B72">2010</xref>, <xref ref-type="bibr" rid="B71">2012</xref>). Therefore, although an A&#x003B2; effect on inhibitory neurotransmission might be expected, the putative mechanism to detune the network coordination of this system remains unclear.</p>
<p>A&#x003B2;<sub>25&#x02013;35</sub> was found not to affect the active properties of CA3 pyramidal recorded neurons suggesting that A&#x003B2;<sub>25&#x02013;35</sub> does not modify the conductances that mediate active membrane properties such as sodium or potassium voltage-gated channels for spike amplitude (Hille, <xref ref-type="bibr" rid="B26">2001</xref>), BK/SK channels for AHPs (Sah and Faber, <xref ref-type="bibr" rid="B58">2002</xref>) or R-type calcium channels for ADP (Metz et al., <xref ref-type="bibr" rid="B46">2005</xref>). Similar results have also been shown in other AD related regions as amygdala (Ashenafi et al., <xref ref-type="bibr" rid="B4">2005</xref>), septum (Santos-Torres et al., <xref ref-type="bibr" rid="B59">2007</xref>), or cortex (Wang et al., <xref ref-type="bibr" rid="B73">2009</xref>).</p>
<p>On the other hand, A&#x003B2;<sub>25&#x02013;35</sub> induced an Ri increase associated with membrane depolarization. We have previously showed that A&#x003B2;<sub>25&#x02013;35</sub> exerts variable effects on membrane potential and Ri in amygdalar pyramidal neurons, possibly due to a presynaptic mechanism (Ashenafi et al., <xref ref-type="bibr" rid="B4">2005</xref>) and in septal neurons, depending on pre- and postsynaptic actions (Santos-Torres et al., <xref ref-type="bibr" rid="B59">2007</xref>). In the present study, TTX was not able to prevent A&#x003B2;<sub>25&#x02013;35</sub> effects suggesting a direct effect of A&#x003B2;<sub>25&#x02013;35</sub> on CA3 pyramidal neurons membrane.</p>
<p>Previous research has shown that neurotransmission in the septohippocampal system is affected by A&#x003B2; through altering the <italic>theta</italic> oscillatory activity (Colom et al., <xref ref-type="bibr" rid="B19">2010</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>), but studies at the synaptic level on the mechanisms underlying this alteration have not been exhaustively performed. Thus, the possibility of studying in a single preparation and in a particular synapse, excitatory and inhibitory neurotransmission, presents fimbria-CA3 synapse preparation as an excellent model for dissecting the possible mechanisms involved in A&#x003B2; action on different septohippocampal neurotransmission systems.</p>
<p>A biphasic (glutamatergic, non-NMDA, and GABAergic, GABA<sub>A</sub>) response in CA3 region after fimbria stimulation (Schneiderman et al., <xref ref-type="bibr" rid="B61">1992</xref>) has previously been reported. However, we found a complex synaptic response comprising three phases: an ionotropic glutamatergic EPSP (Huh et al., <xref ref-type="bibr" rid="B28">2010</xref>) followed by two IPSPs, early (GABA<sub>A</sub>), and late (GABA<sub>B</sub>). This complex response has also been described in pyramidal neurons of basolateral amygdaloid nucleus (Washburn and Moises, <xref ref-type="bibr" rid="B74">1992a</xref>), in CA3 pyramidal cells after hilus and mossy fibers stimulation (Malouf et al., <xref ref-type="bibr" rid="B43">1990</xref>; Scanziani et al., <xref ref-type="bibr" rid="B60">1991</xref>). In our study, the inhibitory feedback seems to be mediated by activation of GABAergic interneurons and depends on glutamatergic activation, since the block of EPSP also eliminated both IPSPs. The loss of GABA<sub>A</sub> inhibition led to an increase in EPSP and late IPSP amplitudes whereas complete GABAergic component block induced an epileptic-like response mainly mediated by non-NMDA receptors, although NMDA antagonist reduced the response partially. Very similar results have been shown in neurons from CA3 hippocampal region (Scanziani et al., <xref ref-type="bibr" rid="B60">1991</xref>) or frontal cortex (Sutor and Luhmann, <xref ref-type="bibr" rid="B67">1998</xref>) possibly caused by an increased excitation of interneurons arising from disinhibited excitatory neurons, and disinhibition of interneurons due to block of GABA<sub>A</sub> receptors on the inhibitory cell. This machinery has been suggested as a self-protective mechanism for the control of recurrent activity when an imbalance of the system occurs (Scanziani et al., <xref ref-type="bibr" rid="B60">1991</xref>; Sutor and Luhmann, <xref ref-type="bibr" rid="B67">1998</xref>).</p>
<p>On the other hand, although it has been reported that cholinergic septal neurons innervate pyramidal CA3 neurons and interneurons (Widmer et al., <xref ref-type="bibr" rid="B77">2006</xref>), it is also known that cholinergic axons must be activated by train stimulation (&#x0003E;30 Hz) (Washburn and Moises, <xref ref-type="bibr" rid="B75">1992b</xref>; Faber and Sah, <xref ref-type="bibr" rid="B23">2002</xref>; Navarro-Lopez et al., <xref ref-type="bibr" rid="B51">2004</xref>). It can therefore be suggested that cholinergic axons projecting onto CA3 neurons were not activated during single stimulation of the fimbria.</p>
</sec>
<sec>
<title>A&#x003B2;<sub>25&#x02013;35</sub> effects on the complex fimbria-CA3 synaptic response</title>
<p>In the present study, pharmacological characterization of the complex septohippocampal synaptic response revealed the glutamatergic nature of the EPSP. Glutamatergic septohippocampal neurons (Colom et al., <xref ref-type="bibr" rid="B20">2005</xref>; Huh et al., <xref ref-type="bibr" rid="B28">2010</xref>) have shown spontaneous firing at <italic>theta</italic> frequencies and A&#x003B2; increases this frequency (Leao et al., <xref ref-type="bibr" rid="B35">2012</xref>), suggesting A&#x003B2; to be likely to impair septohippocampal excitatory and network activity through more than one mechanism.</p>
<p>We found A&#x003B2;<sub>25&#x02013;35</sub> to increase the EPSP. This result may be explained because excitatory response is strongly braked by the GABA<sub>B</sub> activity (Otmakhova and Lisman, <xref ref-type="bibr" rid="B52">2004</xref>; Chen and Johnston, <xref ref-type="bibr" rid="B15">2005</xref>), and A&#x003B2;<sub>25&#x02013;35</sub> diminished late IPSP. Since late IPSP was generated by GABA<sub>B</sub> receptors stimulation, an A&#x003B2;<sub>25&#x02013;35</sub> effect on such receptors, on its intracellular signaling mechanism, or on its final effector, GirK channels, could be hypothesized. Assuming that the early GABA<sub>A</sub> component is not affected by A&#x003B2;<sub>25&#x02013;35</sub>, the reduction of GABA<sub>B</sub> component would not be due to an inhibition of GABA release or other presynaptic mechanism. Together with Ri increase and membrane depolarization, our results lead to a reduction of the conductance of potassium channels coupled to GABA<sub>B</sub> receptor.</p>
<p>Binding studies in postmortem AD patients have shown a reduction in GABA receptors density in the hippocampus (Chu et al., <xref ref-type="bibr" rid="B16">1987</xref>). More recently, the 17A polymerase has been described to be responsible for generating alternative splicing of GABA<sub>B2</sub> subunit in AD patients (Massone et al., <xref ref-type="bibr" rid="B44">2011</xref>). This modification affects intracellular signaling pathway and activation of GirK channels, and is also associated with an increased secretion of A&#x003B2;, suggesting a relationship between the metabolism of APP protein and dysfunction in the GABA<sub>B</sub> receptor signaling.</p>
</sec>
<sec>
<title>A&#x003B2;<sub>25&#x02013;35</sub> action on GirK channels</title>
<p>When fimbria is stimulated, GABAergic interneurons activate GABA<sub>B</sub> receptors of CA3 pyramidal cells; A&#x003B2;<sub>25&#x02013;35</sub> behaves as a selective antagonist and reduces late IPSP. However, the GABA<sub>B</sub> system has a very low tonic activity in basal conditions, and only when the system is activated pharmacologically or by afferent stimulation, the antagonist effect becomes obvious (Bowery and Smart, <xref ref-type="bibr" rid="B11">2006</xref>) as occurs, for example, in chronic pain (Malcangio and Bowery, <xref ref-type="bibr" rid="B42">1994</xref>). For this reason, blocking GABA<sub>B</sub> receptors induces little effects on membrane properties, i.e., membrane potential or Ri (Lambert et al., <xref ref-type="bibr" rid="B34">1989</xref>; Emri et al., <xref ref-type="bibr" rid="B22">1996</xref>), so GABA<sub>B</sub> receptor antagonism would not explain all the effects induced by A&#x003B2;<sub>25&#x02013;35</sub>.</p>
<p>Another aspect to consider is that both, GABA<sub>B</sub> receptors and GirK channels are coupled and co-expressed in the postsynaptic membrane of CA3 pyramidal neurons (Luscher et al., <xref ref-type="bibr" rid="B39">1997</xref>; Kulik et al., <xref ref-type="bibr" rid="B33">2003</xref>; Lujan et al., <xref ref-type="bibr" rid="B38">2009</xref>) conforming an oligomeric stable molecular complex (Lujan et al., <xref ref-type="bibr" rid="B38">2009</xref>; Ciruela et al., <xref ref-type="bibr" rid="B17">2010</xref>). Therefore, A&#x003B2;<sub>25&#x02013;35</sub> action on the membrane should include the effector coupled to GABA<sub>B</sub> receptor. GirK channels exhibit a tonic basal activity, even without receptor signaling, due to their direct binding to the G&#x003B1; subunit of G proteins (Lujan et al., <xref ref-type="bibr" rid="B38">2009</xref>). Hence, administration of GirK channel selective antagonist (tertiapin-Q) simulates all the effects of A&#x003B2;<sub>25&#x02013;35</sub> on the postsynaptic membrane, i.e., late IPSP reduction, Ri increase and membrane depolarization, even in the presence of GirK and GABA<sub>B</sub> agonists. Furthermore, A&#x003B2;<sub>25&#x02013;35</sub> was found to be unable to generate an additional significant increase in Ri after pharmacological blocking of GirK channels. These results not only suggest that GirK channels are functional in the basal state, but also that A&#x003B2;<sub>25&#x02013;35</sub> action seems to be more evident when these GirK channels are activated.</p>
<p>GirK channels activity alteration may have multiple implications for synaptic activity and neuronal network function. Numerous studies have emphasized its role in several pathological processes in the nervous system such as epilepsy, pain, addiction, Parkinson or Down syndrome (Luscher and Slesinger, <xref ref-type="bibr" rid="B40">2010</xref>). Deletion studies of GirK channels have revealed their role in learning and memory processes. GIRK4 knock-out mice exhibited impaired performance in spatial learning and memory test (Wickman et al., <xref ref-type="bibr" rid="B76">2000</xref>). Moreover, mutations in GIRK2 subunit reduced LTP and increased LTD in hippocampus (Sago et al., <xref ref-type="bibr" rid="B57">1998</xref>; Siarey et al., <xref ref-type="bibr" rid="B62">1999</xref>; Luscher and Slesinger, <xref ref-type="bibr" rid="B40">2010</xref>) and it is especially relevant in Down syndrome, where cerebral A&#x003B2; accumulation is greatly accelerated and leads to invariant early-onset AD neuropathology (Lott and Head, <xref ref-type="bibr" rid="B36">2005</xref>; Moncaster et al., <xref ref-type="bibr" rid="B48">2010</xref>; Cooper et al., <xref ref-type="bibr" rid="B21">2012</xref>).</p>
<p>The present study proposes a putative synaptic mechanism for neural network hyperactivity, which is considered as an early event in AD pathogenesis and is associated with early A&#x003B2; deposition in non-demented humans with or without mild cognitive impairment (Sperling et al., <xref ref-type="bibr" rid="B64">2009</xref>). An alteration in GirK channel conductance of pyramidal CA3 neurons might underlie this hyperactivity and the impaired inhibition which has been related to network dysfunction and alteration of rhythm generation required for information processing and memory storage in the septohippocampal system (Palop et al., <xref ref-type="bibr" rid="B53">2007</xref>; Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>; Villette et al., <xref ref-type="bibr" rid="B72">2010</xref>, <xref ref-type="bibr" rid="B71">2012</xref>; Rubio et al., <xref ref-type="bibr" rid="B56">2012</xref>; Verret et al., <xref ref-type="bibr" rid="B70">2012</xref>). Our data could be in accordance to the notion that reducing network hyperactivity would have beneficial effects on cognitive functions (Palop and Mucke, <xref ref-type="bibr" rid="B54">2010</xref>; Verret et al., <xref ref-type="bibr" rid="B70">2012</xref>). Subsequently, the present work shows GirK channel as a new target to study A&#x003B2; pathophysiology in early and mild cognitive impairment in AD. Since cholinergic or glutamatergic treatments in AD have shown limited success, therapies combining modulators of different neurotransmission systems seem to be a more promising tool for the treatment, and overall prevention, of this dementia.</p>
</sec>
</sec>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</body>
<back>
<ack>
<p>This work was supported by Spanish MINECO Grants BFU2009-07341 (Javier Yajeya) and SAF2010-14878, BFU2011-22740 (Juan D. Navarro-Lopez). The research leading to these results also received funding (Juan D. Navarro-Lopez) from Fundaci&#x000F3;n Eugenio Rodr&#x000ED;guez Pascual. Juan D. Navarro-Lopez held a <italic>Ram&#x000F3;n y Cajal</italic> Research Fellow (RYC-2009-03827). We thank Drs. A. Munera and D. Soto for their enlightening comments about this work, N. Gonzalez for her excellent technical assistance and Eureka-science for its help in manuscript editing.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname> <given-names>A.</given-names></name> <name><surname>Kohler</surname> <given-names>C.</given-names></name></person-group> (<year>1984</year>). <article-title>A study of the reciprocal connections between the septum and the entorhinal area using anterograde and retrograde axonal transport methods in the rat brain</article-title>. <source>J. Comp. Neurol</source>. <volume>225</volume>, <fpage>327</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1002/cne.902250303</pub-id><pub-id pub-id-type="pmid">6725648</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Amaral</surname> <given-names>D. G.</given-names></name> <name><surname>Lavenex</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Hippocampal neuroanatomy</article-title>, in <source>The Hippocampus Book</source>, eds <person-group person-group-type="editor"><name><surname>Andersen</surname> <given-names>P.</given-names></name> <name><surname>Morris</surname> <given-names>R.</given-names></name> <name><surname>Amaral</surname> <given-names>D. G.</given-names></name> <name><surname>Bliss</surname> <given-names>T.</given-names></name> <name><surname>O&#x00027;Keefe</surname> <given-names>J.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>37</fpage>&#x02013;<lpage>114</lpage>.</citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aryal</surname> <given-names>P.</given-names></name> <name><surname>Dvir</surname> <given-names>H.</given-names></name> <name><surname>Choe</surname> <given-names>S.</given-names></name> <name><surname>Slesinger</surname> <given-names>P. A.</given-names></name></person-group> (<year>2009</year>). <article-title>A discrete alcohol pocket involved in GIRK channel activation</article-title>. <source>Nat. Neurosci</source>. <volume>12</volume>, <fpage>988</fpage>&#x02013;<lpage>995</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2358</pub-id><pub-id pub-id-type="pmid">19561601</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashenafi</surname> <given-names>S.</given-names></name> <name><surname>Fuente</surname> <given-names>A.</given-names></name> <name><surname>Criado</surname> <given-names>J. M.</given-names></name> <name><surname>Riolobos</surname> <given-names>A. S.</given-names></name> <name><surname>Heredia</surname> <given-names>M.</given-names></name> <name><surname>Yajeya</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Beta-Amyloid peptide 25&#x02013;35 depresses excitatory synaptic transmission in the rat basolateral amygdala &#x0201C;<italic>in vitro</italic>&#x0201D;</article-title>. <source>Neurobiol. Aging</source> <volume>26</volume>, <fpage>419</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.05.008</pub-id><pub-id pub-id-type="pmid">15653170</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bischofberger</surname> <given-names>J.</given-names></name> <name><surname>Engel</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Geiger</surname> <given-names>J. R.</given-names></name> <name><surname>Jonas</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Patch-clamp recording from mossy fiber terminals in hippocampal slices</article-title>. <source>Nat. Protoc</source>. <volume>1</volume>, <fpage>2075</fpage>&#x02013;<lpage>2081</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.312</pub-id><pub-id pub-id-type="pmid">17487197</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname> <given-names>B. J.</given-names></name> <name><surname>Stockwell</surname> <given-names>B. R.</given-names></name> <name><surname>Ingram</surname> <given-names>V. M.</given-names></name></person-group> (<year>2002a</year>). <article-title>Eliminating membrane depolarization caused by the Alzheimer peptide Abeta(1-42, aggr.)</article-title>. <source>Biochem. Biophys. Res. Commun</source>. <volume>293</volume>, <fpage>1204</fpage>&#x02013;<lpage>1208</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00290-5</pub-id><pub-id pub-id-type="pmid">12054503</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname> <given-names>B. J.</given-names></name> <name><surname>Thomas</surname> <given-names>V. L.</given-names></name> <name><surname>Ingram</surname> <given-names>V. M.</given-names></name></person-group> (<year>2002b</year>). <article-title>Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide</article-title>. <source>Biochem. Biophys. Res. Commun</source>. <volume>293</volume>, <fpage>1197</fpage>&#x02013;<lpage>1203</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00346-7</pub-id><pub-id pub-id-type="pmid">12054502</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname> <given-names>B. H.</given-names></name> <name><surname>Colom</surname> <given-names>L. V.</given-names></name></person-group> (<year>1993</year>). <article-title>Extrinsic and intrinsic properties underlying oscillation and synchrony in limbic cortex</article-title>. <source>Prog. Neurobiol</source>. <volume>41</volume>, <fpage>157</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(93)90007-F</pub-id><pub-id pub-id-type="pmid">8332751</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname> <given-names>B. H.</given-names></name> <name><surname>Oddie</surname> <given-names>S. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Theta band oscillation and synchrony in the hippocampal formation and associated structures: the case for its role in sensorimotor integration</article-title>. <source>Behav. Brain Res</source>. <volume>127</volume>, <fpage>119</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-4328(01)00358-8</pub-id><pub-id pub-id-type="pmid">11718888</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borhegyi</surname> <given-names>Z.</given-names></name> <name><surname>Varga</surname> <given-names>V.</given-names></name> <name><surname>Szilagyi</surname> <given-names>N.</given-names></name> <name><surname>Fabo</surname> <given-names>D.</given-names></name> <name><surname>Freund</surname> <given-names>T. F.</given-names></name></person-group> (<year>2004</year>). <article-title>Phase segregation of medial septal GABAergic neurons during hippocampal theta activity</article-title>. <source>J. Neurosci</source>. <volume>24</volume>, <fpage>8470</fpage>&#x02013;<lpage>8479</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1413-04.2004</pub-id><pub-id pub-id-type="pmid">15456820</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowery</surname> <given-names>N. G.</given-names></name> <name><surname>Smart</surname> <given-names>T. G.</given-names></name></person-group> (<year>2006</year>). <article-title>GABA and glycine as neurotransmitters: a brief history</article-title>. <source>Br. J. Pharmacol</source>. <volume>147</volume> <supplement>(Suppl. 1)</supplement>, <fpage>S109</fpage>&#x02013;<lpage>S119</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706443</pub-id><pub-id pub-id-type="pmid">16402094</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buzsaki</surname> <given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Theta oscillations in the hippocampus</article-title>. <source>Neuron</source> <volume>33</volume>, <fpage>325</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00586-X</pub-id><pub-id pub-id-type="pmid">11832222</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chamberland</surname> <given-names>S.</given-names></name> <name><surname>Salesse</surname> <given-names>C.</given-names></name> <name><surname>Topolnik</surname> <given-names>D.</given-names></name> <name><surname>Topolnik</surname> <given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Synapse-specific inhibitory control of hippocampal feedback inhibitory circuit</article-title>. <source>Front. Cell. Neurosci</source>. <volume>4</volume>:<issue>130</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2010.00130</pub-id><pub-id pub-id-type="pmid">21060720</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>Z.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wei</surname> <given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Interactions of Abeta25&#x02013;35 beta-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: an all-atom molecular dynamics study</article-title>. <source>J. Phys. Chem. B</source> <volume>115</volume>, <fpage>1165</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1021/jp107558e</pub-id><pub-id pub-id-type="pmid">21192698</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Johnston</surname> <given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Constitutively active G-protein-gated inwardly rectifying K&#x0002B; channels in dendrites of hippocampal CA1 pyramidal neurons</article-title>. <source>J. Neurosci</source>. <volume>25</volume>, <fpage>3787</fpage>&#x02013;<lpage>3792</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5312-04.2005</pub-id><pub-id pub-id-type="pmid">15829630</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>D. C.</given-names></name> <name><surname>Penney</surname> <given-names>J. B.</given-names> <suffix>Jr.</suffix></name> <name><surname>Young</surname> <given-names>A. B.</given-names></name></person-group> (<year>1987</year>). <article-title>Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer&#x00027;s disease</article-title>. <source>Neurosci. Lett</source>. <volume>82</volume>, <fpage>246</fpage>&#x02013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(87)90264-3</pub-id><pub-id pub-id-type="pmid">2827074</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciruela</surname> <given-names>F.</given-names></name> <name><surname>Fernandez-Duenas</surname> <given-names>V.</given-names></name> <name><surname>Sahlholm</surname> <given-names>K.</given-names></name> <name><surname>Fernandez-Alacid</surname> <given-names>L.</given-names></name> <name><surname>Nicolau</surname> <given-names>J. C.</given-names></name> <name><surname>Watanabe</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits</article-title>. <source>Eur. J Neurosci</source>. <volume>32</volume>, <fpage>1265</fpage>&#x02013;<lpage>1277</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07356.x</pub-id><pub-id pub-id-type="pmid">20846323</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname> <given-names>L. V.</given-names></name></person-group> (<year>2006</year>). <article-title>Septal networks: relevance to theta rhythm, epilepsy and Alzheimer&#x00027;s disease</article-title>. <source>J. Neurochem</source>. <volume>96</volume>, <fpage>609</fpage>&#x02013;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03630.x</pub-id><pub-id pub-id-type="pmid">16405497</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname> <given-names>L. V.</given-names></name> <name><surname>Castaneda</surname> <given-names>M. T.</given-names></name> <name><surname>Banuelos</surname> <given-names>C.</given-names></name> <name><surname>Puras</surname> <given-names>G.</given-names></name> <name><surname>Garcia-Hernandez</surname> <given-names>A.</given-names></name> <name><surname>Hernandez</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function</article-title>. <source>Neurobiol. Aging</source> <volume>31</volume>, <fpage>46</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.05.006</pub-id><pub-id pub-id-type="pmid">18547680</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname> <given-names>L. V.</given-names></name> <name><surname>Castaneda</surname> <given-names>M. T.</given-names></name> <name><surname>Reyna</surname> <given-names>T.</given-names></name> <name><surname>Hernandez</surname> <given-names>S.</given-names></name> <name><surname>Garrido-Sanabria</surname> <given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Characterization of medial septal glutamatergic neurons and their projection to the hippocampus</article-title>. <source>Synapse</source> <volume>58</volume>, <fpage>151</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20184</pub-id><pub-id pub-id-type="pmid">16108008</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>A.</given-names></name> <name><surname>Grigoryan</surname> <given-names>G.</given-names></name> <name><surname>Guy-David</surname> <given-names>L.</given-names></name> <name><surname>Tsoory</surname> <given-names>M. M.</given-names></name> <name><surname>Chen</surname> <given-names>A.</given-names></name> <name><surname>Reuveny</surname> <given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Trisomy of the G protein-coupled K&#x0002B; channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>109</volume>, <fpage>2642</fpage>&#x02013;<lpage>2647</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1109099109</pub-id><pub-id pub-id-type="pmid">22308328</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emri</surname> <given-names>Z.</given-names></name> <name><surname>Turner</surname> <given-names>J. P.</given-names></name> <name><surname>Crunelli</surname> <given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title>Tonic activation of presynaptic GABA(B) receptors on thalamic sensory afferents</article-title>. <source>Neuroscience</source> <volume>72</volume>, <fpage>689</fpage>&#x02013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(95)00590-0</pub-id><pub-id pub-id-type="pmid">9157315</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname> <given-names>E. S.</given-names></name> <name><surname>Sah</surname> <given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Physiological role of calcium-activated potassium currents in the rat lateral amygdala</article-title>. <source>J. Neurosci</source>. <volume>22</volume>, <fpage>1618</fpage>&#x02013;<lpage>1628</lpage>. <pub-id pub-id-type="pmid">11880492</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freund</surname> <given-names>T. F.</given-names></name> <name><surname>Antal</surname> <given-names>M.</given-names></name></person-group> (<year>1988</year>). <article-title>GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus</article-title>. <source>Nature</source> <volume>336</volume>, <fpage>170</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1038/336170a0</pub-id><pub-id pub-id-type="pmid">3185735</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloveli</surname> <given-names>T.</given-names></name> <name><surname>Dugladze</surname> <given-names>T.</given-names></name> <name><surname>Rotstein</surname> <given-names>H. G.</given-names></name> <name><surname>Traub</surname> <given-names>R. D.</given-names></name> <name><surname>Monyer</surname> <given-names>H.</given-names></name> <name><surname>Heinemann</surname> <given-names>U.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Orthogonal arrangement of rhythm-generating microcircuits in the hippocampus</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>102</volume>, <fpage>13295</fpage>&#x02013;<lpage>13300</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506259102</pub-id><pub-id pub-id-type="pmid">16141320</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Hille</surname> <given-names>B.</given-names></name></person-group> (<year>2001</year>). <source>Ion Channels of Excitable Membranes</source>. <publisher-loc>Sunderland, MA</publisher-loc>: <publisher-name>Sinauer associates</publisher-name>.</citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Mucke</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Alzheimer mechanisms and therapeutic strategies</article-title>. <source>Cell</source> <volume>148</volume>, <fpage>1204</fpage>&#x02013;<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.040</pub-id><pub-id pub-id-type="pmid">22424230</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname> <given-names>C. Y.</given-names></name> <name><surname>Goutagny</surname> <given-names>R.</given-names></name> <name><surname>Williams</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutamatergic neurons of the mouse medial septum and diagonal band of Broca synaptically drive hippocampal pyramidal cells: relevance for hippocampal theta rhythm</article-title>. <source>J. Neurosci</source>. <volume>30</volume>, <fpage>15951</fpage>&#x02013;<lpage>15961</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3663-10.2010</pub-id><pub-id pub-id-type="pmid">21106833</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Arce</surname> <given-names>F. T.</given-names></name> <name><surname>Ramachandran</surname> <given-names>S.</given-names></name> <name><surname>Capone</surname> <given-names>R.</given-names></name> <name><surname>Azimova</surname> <given-names>R.</given-names></name> <name><surname>Kagan</surname> <given-names>B. L.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer&#x00027;s Disease and Down syndrome</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>107</volume>, <fpage>6538</fpage>&#x02013;<lpage>6543</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914251107</pub-id><pub-id pub-id-type="pmid">20308552</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaupmann</surname> <given-names>K.</given-names></name> <name><surname>Schuler</surname> <given-names>V.</given-names></name> <name><surname>Mosbacher</surname> <given-names>J.</given-names></name> <name><surname>Bischoff</surname> <given-names>S.</given-names></name> <name><surname>Bittiger</surname> <given-names>H.</given-names></name> <name><surname>Heid</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K&#x0002B; channels</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>95</volume>, <fpage>14991</fpage>&#x02013;<lpage>14996</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.25.14991</pub-id><pub-id pub-id-type="pmid">9844003</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klementiev</surname> <given-names>B.</given-names></name> <name><surname>Novikova</surname> <given-names>T.</given-names></name> <name><surname>Novitskaya</surname> <given-names>V.</given-names></name> <name><surname>Walmod</surname> <given-names>P. S.</given-names></name> <name><surname>Dmytriyeva</surname> <given-names>O.</given-names></name> <name><surname>Pakkenberg</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25&#x02013;35</article-title>. <source>Neuroscience</source> <volume>145</volume>, <fpage>209</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.11.060</pub-id><pub-id pub-id-type="pmid">17223274</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname> <given-names>C.</given-names></name> <name><surname>Chan-Palay</surname> <given-names>V.</given-names></name> <name><surname>Wu</surname> <given-names>J. Y.</given-names></name></person-group> (<year>1984</year>). <article-title>Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain</article-title>. <source>Anat. Embryol. (Berl.)</source> <volume>169</volume>, <fpage>41</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/BF00300585</pub-id><pub-id pub-id-type="pmid">6721220</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kulik</surname> <given-names>A.</given-names></name> <name><surname>Vida</surname> <given-names>I.</given-names></name> <name><surname>Lujan</surname> <given-names>R.</given-names></name> <name><surname>Haas</surname> <given-names>C. A.</given-names></name> <name><surname>Lopez-Bendito</surname> <given-names>G.</given-names></name> <name><surname>Shigemoto</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and GABA(B2) in the rat hippocampus</article-title>. <source>J. Neurosci</source>. <volume>23</volume>, <fpage>11026</fpage>&#x02013;<lpage>11035</lpage>. <pub-id pub-id-type="pmid">14657159</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname> <given-names>N. A.</given-names></name> <name><surname>Harrison</surname> <given-names>N. L.</given-names></name> <name><surname>Kerr</surname> <given-names>D. I.</given-names></name> <name><surname>Ong</surname> <given-names>J.</given-names></name> <name><surname>Prager</surname> <given-names>R. H.</given-names></name> <name><surname>Teyler</surname> <given-names>T. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Blockade of the late IPSP in rat CA1 hippocampal neurons by 2-hydroxy-saclofen</article-title>. <source>Neurosci. Lett</source>. <volume>107</volume>, <fpage>125</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(89)90803-3</pub-id><pub-id pub-id-type="pmid">2559366</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leao</surname> <given-names>R. N.</given-names></name> <name><surname>Colom</surname> <given-names>L. V.</given-names></name> <name><surname>Borgius</surname> <given-names>L.</given-names></name> <name><surname>Kiehn</surname> <given-names>O.</given-names></name> <name><surname>Fisahn</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Medial septal dysfunction by Abeta-induced KCNQ channel-block in glutamatergic neurons</article-title>. <source>Neurobiol. Aging</source> <volume>33</volume>, <fpage>2046</fpage>&#x02013;<lpage>2061</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.07.013</pub-id><pub-id pub-id-type="pmid">21907458</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lott</surname> <given-names>I. T.</given-names></name> <name><surname>Head</surname> <given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Alzheimer disease and Down syndrome: factors in pathogenesis</article-title>. <source>Neurobiol. Aging</source> <volume>26</volume>, <fpage>383</fpage>&#x02013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.08.005</pub-id><pub-id pub-id-type="pmid">15639317</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lujan</surname> <given-names>R.</given-names></name> <name><surname>Ciruela</surname> <given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>GABAB receptors-associated proteins: potential drug targets in neurological disorders?</article-title> <source>Curr. Drug Targets</source> <volume>13</volume>, <fpage>129</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.2174/138945012798868425</pub-id><pub-id pub-id-type="pmid">22023408</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lujan</surname> <given-names>R.</given-names></name> <name><surname>Maylie</surname> <given-names>J.</given-names></name> <name><surname>Adelman</surname> <given-names>J. P.</given-names></name></person-group> (<year>2009</year>). <article-title>New sites of action for GIRK and SK channels</article-title>. <source>Nat. Rev. Neurosci</source>. <volume>10</volume>, <fpage>475</fpage>&#x02013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2668</pub-id><pub-id pub-id-type="pmid">19543219</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luscher</surname> <given-names>C.</given-names></name> <name><surname>Jan</surname> <given-names>L. Y.</given-names></name> <name><surname>Stoffel</surname> <given-names>M.</given-names></name> <name><surname>Malenka</surname> <given-names>R. C.</given-names></name> <name><surname>Nicoll</surname> <given-names>R. A.</given-names></name></person-group> (<year>1997</year>). <article-title>G protein-coupled inwardly rectifying K&#x0002B; channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons</article-title>. <source>Neuron</source> <volume>19</volume>, <fpage>687</fpage>&#x02013;<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80381-5</pub-id><pub-id pub-id-type="pmid">9331358</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luscher</surname> <given-names>C.</given-names></name> <name><surname>Slesinger</surname> <given-names>P. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease</article-title>. <source>Nat. Rev. Neurosci</source>. <volume>11</volume>, <fpage>301</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2834</pub-id><pub-id pub-id-type="pmid">20389305</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>G.</given-names></name> <name><surname>Rose</surname> <given-names>G.</given-names></name> <name><surname>Gall</surname> <given-names>C.</given-names></name></person-group> (<year>1977</year>). <article-title>Anatomical and functional aspects of the septo-hippocampal projections</article-title>. <source>Ciba Found. Symp</source>. <volume>58</volume>, <fpage>5</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="pmid">83225</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malcangio</surname> <given-names>M.</given-names></name> <name><surname>Bowery</surname> <given-names>N. G.</given-names></name></person-group> (<year>1994</year>). <article-title>Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system</article-title>. <source>Br. J. Pharmacol</source>. <volume>113</volume>, <fpage>1561</fpage>&#x02013;<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1994.tb17174.x</pub-id><pub-id pub-id-type="pmid">7534191</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malouf</surname> <given-names>A. T.</given-names></name> <name><surname>Robbins</surname> <given-names>C. A.</given-names></name> <name><surname>Schwartzkroin</surname> <given-names>P. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Phaclofen inhibition of the slow inhibitory postsynaptic potential in hippocampal slice cultures: a possible role for the GABAB-mediated inhibitory postsynaptic potential</article-title>. <source>Neuroscience</source> <volume>35</volume>, <fpage>53</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(90)90119-O</pub-id><pub-id pub-id-type="pmid">2359496</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massone</surname> <given-names>S.</given-names></name> <name><surname>Vassallo</surname> <given-names>I.</given-names></name> <name><surname>Fiorino</surname> <given-names>G.</given-names></name> <name><surname>Castelnuovo</surname> <given-names>M.</given-names></name> <name><surname>Barbieri</surname> <given-names>F.</given-names></name> <name><surname>Borghi</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease</article-title>. <source>Neurobiol. Dis</source>. <volume>41</volume>, <fpage>308</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.09.019</pub-id><pub-id pub-id-type="pmid">20888417</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname> <given-names>G.</given-names></name> <name><surname>Drachman</surname> <given-names>D.</given-names></name> <name><surname>Folstein</surname> <given-names>M.</given-names></name> <name><surname>Katzman</surname> <given-names>R.</given-names></name> <name><surname>Price</surname> <given-names>D.</given-names></name> <name><surname>Stadlan</surname> <given-names>E. M.</given-names></name></person-group> (<year>1984</year>). <article-title>Clinical diagnosis of Alzheimer&#x00027;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x00027;s Disease</article-title>. <source>Neurology</source> <volume>34</volume>, <fpage>939</fpage>&#x02013;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.34.7.939</pub-id><pub-id pub-id-type="pmid">6610841</pub-id></citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metz</surname> <given-names>A. E.</given-names></name> <name><surname>Jarsky</surname> <given-names>T.</given-names></name> <name><surname>Martina</surname> <given-names>M.</given-names></name> <name><surname>Spruston</surname> <given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>R-type calcium channels contribute to afterdepolarization and bursting in hippocampal CA1 pyramidal neurons</article-title>. <source>J. Neurosci</source>. <volume>25</volume>, <fpage>5763</fpage>&#x02013;<lpage>5773</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0624-05.2005</pub-id><pub-id pub-id-type="pmid">15958743</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Millucci</surname> <given-names>L.</given-names></name> <name><surname>Ghezzi</surname> <given-names>L.</given-names></name> <name><surname>Bernardini</surname> <given-names>G.</given-names></name> <name><surname>Santucci</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Conformations and biological activities of amyloid beta peptide 25&#x02013;35</article-title>. <source>Curr. Protein Pept. Sci</source>. <volume>11</volume>, <fpage>54</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.2174/138920310790274626</pub-id><pub-id pub-id-type="pmid">20201807</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moncaster</surname> <given-names>J. A.</given-names></name> <name><surname>Pineda</surname> <given-names>R.</given-names></name> <name><surname>Moir</surname> <given-names>R. D.</given-names></name> <name><surname>Lu</surname> <given-names>S.</given-names></name> <name><surname>Burton</surname> <given-names>M. A.</given-names></name> <name><surname>Ghosh</surname> <given-names>J. G.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Alzheimer&#x00027;s disease amyloid-beta links lens and brain pathology in Down syndrome</article-title>. <source>PLoS ONE</source> <volume>5</volume>:<fpage>e10659</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010659</pub-id><pub-id pub-id-type="pmid">20502642</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname> <given-names>H.</given-names></name> <name><surname>Wu</surname> <given-names>W. E.</given-names></name> <name><surname>Lee</surname> <given-names>T.</given-names></name> <name><surname>Brickman</surname> <given-names>A.</given-names></name> <name><surname>Mayeux</surname> <given-names>R.</given-names></name> <name><surname>Brown</surname> <given-names>T. R.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Imaging the Abeta-related neurotoxicity of Alzheimer disease</article-title>. <source>Arch. Neurol</source>. <volume>64</volume>, <fpage>1467</fpage>&#x02013;<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.10.1467</pub-id><pub-id pub-id-type="pmid">17923630</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname> <given-names>D. D.</given-names></name> <name><surname>Lewis</surname> <given-names>D. V.</given-names></name></person-group> (<year>1994</year>). <article-title>The pharmacology and function of central GABAB receptors</article-title>. <source>Int. Rev. Neurobiol</source>. <volume>36</volume>, <fpage>97</fpage>&#x02013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(08)60304-9</pub-id><pub-id pub-id-type="pmid">7822122</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Lopez</surname> <given-names>J. D.</given-names></name> <name><surname>Alvarado</surname> <given-names>J. C.</given-names></name> <name><surname>Marquez-Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Escudero</surname> <given-names>M.</given-names></name> <name><surname>Delgado-Garcia</surname> <given-names>J. M.</given-names></name> <name><surname>Yajeya</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>A cholinergic synaptically triggered event participates in the generation of persistent activity necessary for eye fixation</article-title>. <source>J. Neurosci</source>. <volume>24</volume>, <fpage>5109</fpage>&#x02013;<lpage>5118</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0235-04.2004</pub-id><pub-id pub-id-type="pmid">15175380</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otmakhova</surname> <given-names>N. A.</given-names></name> <name><surname>Lisman</surname> <given-names>J. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Contribution of Ih and GABAB to synaptically induced afterhyperpolarizations in CA1: a brake on the NMDA response</article-title>. <source>J. Neurophysiol</source>. <volume>92</volume>, <fpage>2027</fpage>&#x02013;<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00427.2004</pub-id><pub-id pub-id-type="pmid">15163674</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palop</surname> <given-names>J. J.</given-names></name> <name><surname>Chin</surname> <given-names>J.</given-names></name> <name><surname>Roberson</surname> <given-names>E. D.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Thwin</surname> <given-names>M. T.</given-names></name> <name><surname>Bien-Ly</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer&#x00027;s disease</article-title>. <source>Neuron</source> <volume>55</volume>, <fpage>697</fpage>&#x02013;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.025</pub-id><pub-id pub-id-type="pmid">17785178</pub-id></citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palop</surname> <given-names>J. J.</given-names></name> <name><surname>Mucke</surname> <given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Amyloid-beta-induced neuronal dysfunction in Alzheimer&#x00027;s disease: from synapses toward neural networks</article-title>. <source>Nat. Neurosci</source>. <volume>13</volume>, <fpage>812</fpage>&#x02013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2583</pub-id><pub-id pub-id-type="pmid">20581818</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x000F1;a</surname> <given-names>F.</given-names></name> <name><surname>Ordaz</surname> <given-names>B.</given-names></name> <name><surname>Balleza-Tapia</surname> <given-names>H.</given-names></name> <name><surname>Bernal-Pedraza</surname> <given-names>R.</given-names></name> <name><surname>Marquez-Ramos</surname> <given-names>A.</given-names></name> <name><surname>Carmona-Aparicio</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Beta-amyloid protein (25&#x02013;35) disrupts hippocampal network activity: role of Fyn-kinase</article-title>. <source>Hippocampus</source> <volume>20</volume>, <fpage>78</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="pmid">19294646</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname> <given-names>S. E.</given-names></name> <name><surname>Vega-Flores</surname> <given-names>G.</given-names></name> <name><surname>Martinez</surname> <given-names>A.</given-names></name> <name><surname>Bosch</surname> <given-names>C.</given-names></name> <name><surname>Perez-Mediavilla</surname> <given-names>A.</given-names></name> <name><surname>Del</surname> <given-names>R. J.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer&#x00027;s disease</article-title>. <source>FASEB J</source>. <volume>26</volume>, <fpage>4458</fpage>&#x02013;<lpage>4467</lpage>. <pub-id pub-id-type="doi">10.1096/fj.12-208413</pub-id><pub-id pub-id-type="pmid">22835830</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sago</surname> <given-names>H.</given-names></name> <name><surname>Carlson</surname> <given-names>E. J.</given-names></name> <name><surname>Smith</surname> <given-names>D. J.</given-names></name> <name><surname>Kilbridge</surname> <given-names>J.</given-names></name> <name><surname>Rubin</surname> <given-names>E. M.</given-names></name> <name><surname>Mobley</surname> <given-names>W. C.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>95</volume>, <fpage>6256</fpage>&#x02013;<lpage>6261</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.11.6256</pub-id><pub-id pub-id-type="pmid">9600952</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname> <given-names>P.</given-names></name> <name><surname>Faber</surname> <given-names>E. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Channels underlying neuronal calcium-activated potassium currents</article-title>. <source>Prog. Neurobiol</source>. <volume>66</volume>, <fpage>345</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(02)00004-7</pub-id><pub-id pub-id-type="pmid">12015199</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santos-Torres</surname> <given-names>J.</given-names></name> <name><surname>Fuente</surname> <given-names>A.</given-names></name> <name><surname>Criado</surname> <given-names>J. M.</given-names></name> <name><surname>Riolobos</surname> <given-names>A. S.</given-names></name> <name><surname>Heredia</surname> <given-names>M.</given-names></name> <name><surname>Yajeya</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum</article-title>. <source>J. Neurosci. Res</source>. <volume>85</volume>, <fpage>634</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21150</pub-id><pub-id pub-id-type="pmid">17171714</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scanziani</surname> <given-names>M.</given-names></name> <name><surname>Gahwiler</surname> <given-names>B. H.</given-names></name> <name><surname>Thompson</surname> <given-names>S. M.</given-names></name></person-group> (<year>1991</year>). <article-title>Paroxysmal inhibitory potentials mediated by GABAB receptors in partially disinhibited rat hippocampal slice cultures</article-title>. <source>J. Physiol</source>. <volume>444</volume>, <fpage>375</fpage>&#x02013;<lpage>396</lpage>. <pub-id pub-id-type="pmid">1688032</pub-id></citation>
</ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneiderman</surname> <given-names>J. H.</given-names></name> <name><surname>Cairns</surname> <given-names>A.</given-names></name> <name><surname>Sterling</surname> <given-names>C. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Evoked CA3 field potentials corresponding to both EPSPs and IPSPs in hippocampal slice</article-title>. <source>Brain Res</source>. <volume>569</volume>, <fpage>287</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(92)90641-L</pub-id><pub-id pub-id-type="pmid">1347244</pub-id></citation>
</ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siarey</surname> <given-names>R. J.</given-names></name> <name><surname>Carlson</surname> <given-names>E. J.</given-names></name> <name><surname>Epstein</surname> <given-names>C. J.</given-names></name> <name><surname>Balbo</surname> <given-names>A.</given-names></name> <name><surname>Rapoport</surname> <given-names>S. I.</given-names></name> <name><surname>Galdzicki</surname> <given-names>Z.</given-names></name></person-group> (<year>1999</year>). <article-title>Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome</article-title>. <source>Neuropharmacology</source> <volume>38</volume>, <fpage>1917</fpage>&#x02013;<lpage>1920</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(99)00083-0</pub-id><pub-id pub-id-type="pmid">10608287</pub-id></citation>
</ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sotty</surname> <given-names>F.</given-names></name> <name><surname>Danik</surname> <given-names>M.</given-names></name> <name><surname>Manseau</surname> <given-names>F.</given-names></name> <name><surname>Laplante</surname> <given-names>F.</given-names></name> <name><surname>Quirion</surname> <given-names>R.</given-names></name> <name><surname>Williams</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity</article-title>. <source>J. Physiol</source>. <volume>551</volume>, <fpage>927</fpage>&#x02013;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2003.046847</pub-id><pub-id pub-id-type="pmid">12865506</pub-id></citation>
</ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sperling</surname> <given-names>R. A.</given-names></name> <name><surname>LaViolette</surname> <given-names>P. S.</given-names></name> <name><surname>O&#x00027;Keefe</surname> <given-names>K.</given-names></name> <name><surname>O&#x00027;Brien</surname> <given-names>J.</given-names></name> <name><surname>Rentz</surname> <given-names>D. M.</given-names></name> <name><surname>Pihlajamaki</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Amyloid deposition is associated with impaired default network function in older persons without dementia</article-title>. <source>Neuron</source> <volume>63</volume>, <fpage>178</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.07.003</pub-id><pub-id pub-id-type="pmid">19640477</pub-id></citation>
</ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spruston</surname> <given-names>N.</given-names></name> <name><surname>Johnston</surname> <given-names>D.</given-names></name></person-group> (<year>1992</year>). <article-title>Perforated patch-clamp analysis of the passive membrane properties of three classes of hippocampal neurons</article-title>. <source>J. Neurophysiol</source>. <volume>67</volume>, <fpage>508</fpage>&#x02013;<lpage>529</lpage>. <pub-id pub-id-type="pmid">1578242</pub-id></citation>
</ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>M.</given-names></name> <name><surname>Fox</surname> <given-names>S. E.</given-names></name></person-group> (<year>1990</year>). <article-title>Do septal neurons pace the hippocampal theta rhythm?</article-title> <source>Trends Neurosci</source>. <volume>13</volume>, <fpage>163</fpage>&#x02013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(90)90040-H</pub-id><pub-id pub-id-type="pmid">1693232</pub-id></citation>
</ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutor</surname> <given-names>B.</given-names></name> <name><surname>Luhmann</surname> <given-names>H. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Involvement of GABA(B) receptors in convulsant-induced epileptiform activity in rat neocortex <italic>in vitro</italic></article-title>. <source>Eur. J Neurosci</source>. <volume>10</volume>, <fpage>3417</fpage>&#x02013;<lpage>3427</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00351.x</pub-id><pub-id pub-id-type="pmid">9824455</pub-id></citation>
</ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanberg</surname> <given-names>M. M.</given-names></name> <name><surname>Tractenberg</surname> <given-names>R. E.</given-names></name> <name><surname>Mohs</surname> <given-names>R.</given-names></name> <name><surname>Thal</surname> <given-names>L. J.</given-names></name> <name><surname>Cummings</surname> <given-names>J. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Executive dysfunction in Alzheimer disease</article-title>. <source>Arch. Neurol</source>. <volume>61</volume>, <fpage>556</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.61.4.556</pub-id><pub-id pub-id-type="pmid">15096405</pub-id></citation>
</ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varadarajan</surname> <given-names>S.</given-names></name> <name><surname>Kanski</surname> <given-names>J.</given-names></name> <name><surname>Aksenova</surname> <given-names>M.</given-names></name> <name><surname>Lauderback</surname> <given-names>C.</given-names></name> <name><surname>Butterfield</surname> <given-names>D. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Different mechanisms of oxidative stress and neurotoxicity for Alzheimer&#x00027;s A beta(1&#x02013;42) and A beta(25&#x02013;35)</article-title>. <source>J. Am. Chem. Soc</source>. <volume>123</volume>, <fpage>5625</fpage>&#x02013;<lpage>5631</lpage>. <pub-id pub-id-type="doi">10.1021/ja010452r</pub-id><pub-id pub-id-type="pmid">11403592</pub-id></citation>
</ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verret</surname> <given-names>L.</given-names></name> <name><surname>Mann</surname> <given-names>E. O.</given-names></name> <name><surname>Hang</surname> <given-names>G. B.</given-names></name> <name><surname>Barth</surname> <given-names>A. M.</given-names></name> <name><surname>Cobos</surname> <given-names>I.</given-names></name> <name><surname>Ho</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>708</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.046</pub-id><pub-id pub-id-type="pmid">22541439</pub-id></citation>
</ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villette</surname> <given-names>V.</given-names></name> <name><surname>Poindessous-Jazat</surname> <given-names>F.</given-names></name> <name><surname>Bellessort</surname> <given-names>B.</given-names></name> <name><surname>Roullot</surname> <given-names>E.</given-names></name> <name><surname>Peterschmitt</surname> <given-names>Y.</given-names></name> <name><surname>Epelbaum</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>A new neuronal target for beta-amyloid peptide in the rat hippocampus</article-title>. <source>Neurobiol. Aging</source> <volume>33</volume>, <fpage>1126</fpage>&#x02013;<lpage>1114</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.11.024</pub-id><pub-id pub-id-type="pmid">22206845</pub-id></citation>
</ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villette</surname> <given-names>V.</given-names></name> <name><surname>Poindessous-Jazat</surname> <given-names>F.</given-names></name> <name><surname>Simon</surname> <given-names>A.</given-names></name> <name><surname>Lena</surname> <given-names>C.</given-names></name> <name><surname>Roullot</surname> <given-names>E.</given-names></name> <name><surname>Bellessort</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-beta pathology in the rat</article-title>. <source>J. Neurosci</source>. <volume>30</volume>, <fpage>10991</fpage>&#x02013;<lpage>11003</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6284-09.2010</pub-id><pub-id pub-id-type="pmid">20720106</pub-id></citation>
</ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>G.</given-names></name> <name><surname>Zhou</surname> <given-names>H.</given-names></name> <name><surname>Barakat</surname> <given-names>A.</given-names></name> <name><surname>Querfurth</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Opposite effects of low and high doses of Abeta42 on electrical network and neuronal excitability in the rat prefrontal cortex</article-title>. <source>PLoS ONE</source> <volume>4</volume>:<fpage>e8366</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008366</pub-id><pub-id pub-id-type="pmid">20027222</pub-id></citation>
</ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Washburn</surname> <given-names>M. S.</given-names></name> <name><surname>Moises</surname> <given-names>H. C.</given-names></name></person-group> (<year>1992a</year>). <article-title>Inhibitory responses of rat basolateral amygdaloid neurons recorded <italic>in vitro</italic></article-title>. <source>Neuroscience</source> <volume>50</volume>, <fpage>811</fpage>&#x02013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(92)90206-H</pub-id><pub-id pub-id-type="pmid">1333061</pub-id></citation>
</ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Washburn</surname> <given-names>M. S.</given-names></name> <name><surname>Moises</surname> <given-names>H. C.</given-names></name></person-group> (<year>1992b</year>). <article-title>Muscarinic responses of rat basolateral amygdaloid neurons recorded <italic>in vitro</italic></article-title>. <source>J. Physiol</source>. <volume>449</volume>, <fpage>121</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="pmid">1522506</pub-id></citation>
</ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wickman</surname> <given-names>K.</given-names></name> <name><surname>Karschin</surname> <given-names>C.</given-names></name> <name><surname>Karschin</surname> <given-names>A.</given-names></name> <name><surname>Picciotto</surname> <given-names>M. R.</given-names></name> <name><surname>Clapham</surname> <given-names>D. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Brain localization and behavioral impact of the G-protein-gated K&#x0002B; channel subunit GIRK4</article-title>. <source>J. Neurosci</source>. <volume>20</volume>, <fpage>5608</fpage>&#x02013;<lpage>5615</lpage>. <pub-id pub-id-type="pmid">10908597</pub-id></citation>
</ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Widmer</surname> <given-names>H.</given-names></name> <name><surname>Ferrigan</surname> <given-names>L.</given-names></name> <name><surname>Davies</surname> <given-names>C. H.</given-names></name> <name><surname>Cobb</surname> <given-names>S. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons</article-title>. <source>Hippocampus</source> <volume>16</volume>, <fpage>617</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20191</pub-id><pub-id pub-id-type="pmid">16770798</pub-id></citation>
</ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wittner</surname> <given-names>L.</given-names></name> <name><surname>Henze</surname> <given-names>D. A.</given-names></name> <name><surname>Zaborszky</surname> <given-names>L.</given-names></name> <name><surname>Buzsaki</surname> <given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Three-dimensional reconstruction of the axon arbor of a CA3 pyramidal cell recorded and filled <italic>in vivo</italic></article-title>. <source>Brain Struct. Funct</source>. <volume>212</volume>, <fpage>75</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-007-0148-y</pub-id><pub-id pub-id-type="pmid">17717699</pub-id></citation>
</ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyss</surname> <given-names>J. M.</given-names></name> <name><surname>Swanson</surname> <given-names>L. W.</given-names></name> <name><surname>Cowan</surname> <given-names>W. M.</given-names></name></person-group> (<year>1980</year>). <article-title>The organization of the fimbria, dorsal fornix and ventral hippocampal commissure in the rat</article-title>. <source>Anat. Embryol. (Berl.)</source> <volume>158</volume>, <fpage>303</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1007/BF00301819</pub-id><pub-id pub-id-type="pmid">7356182</pub-id></citation>
</ref>
<ref id="B80">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yajeya</surname> <given-names>J.</given-names></name> <name><surname>De La Fuente</surname> <given-names>A.</given-names></name> <name><surname>Criado</surname> <given-names>J. M.</given-names></name> <name><surname>Bajo</surname> <given-names>V.</given-names></name> <name><surname>Sanchez-Riolobos</surname> <given-names>A.</given-names></name> <name><surname>Heredia</surname> <given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Muscarinic agonist carbachol depresses excitatory synaptic transmission in the rat basolateral amygdala <italic>in vitro</italic></article-title>. <source>Synapse</source> <volume>38</volume>, <fpage>151</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="pmid">11018789</pub-id></citation>
</ref>
</ref-list>
</back>
</article>